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Abstract 
Obstructive lung disease, including asthma and chronic obstructive pulmonary disease 
(COPD), is characterized by heterogeneous ventilation. Unfortunately, the underlying 
structure-function relationships and the relationships between measurements of heterogeneity 
and patient quality-of-life in obstructive lung disease are not well understood.  Hyperpolarized 
noble gas MRI is used to visualize and quantify ventilation distribution and the forced 
oscillation technique (FOT) applies a multi-frequency pressure oscillation at the mouth to 
measure respiratory impedance to airflow (including resistance and reactance).  My objective 
was to use FOT, ventilation MRI and computational airway tree modeling to better understand 
ventilation heterogeneity in asthma and COPD.  FOT-measured respiratory system impedance 
was correlated with MRI ventilation heterogeneity and both were related to quality-of-life in 
asthma and COPD. FOT-measurements and model-predictions of reactance and small-airways 
resistance were correlated in asthma and COPD respectively.  This study is the first to 
demonstrate the relationships between FOT-measured impedance, MRI ventilation 
heterogeneity, and patient quality-of-life. 
Keywords 
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CHAPTER 1 
1 INTRODUCTION 
Ventilation heterogeneity is a hallmark characteristic of obstructive lung diseases such as 
asthma and chronic obstructive pulmonary disease (COPD), and is related to airflow 
obstruction.  In this thesis, the nature of ventilation heterogeneity is studied using 
measurements of biomechanical properties of the lung, pulmonary imaging and 
computational modeling of lung mechanics to better understand how these measures are 
related to patient outcomes. 
1.1 Motivation and Rationale 
Obstructive lung disease creates a tremendous global burden; chronic obstructive 
pulmonary disease (COPD) affects 175 million people worldwide and was responsible for 
3.2 million deaths in 2015.1  Asthma is the most prevalent chronic respiratory disease 
worldwide, affecting 358 million people, and was responsible for 0.4 million deaths in 
2015.1  Among all chronic respiratory diseases, obstructive lung disease is a leading cause 
of global death, as shown in Figure 1-1.  
 
Figure 1-1 Global Deaths Due to Chronic Respiratory Disease 
This graph shows the number of deaths globally from chronic lung disease in 2015 using 
a logarithmic scale.  On the left, COPD (n=3.2 million) and asthma (n=0.4 million) are the 
leading causes of death among all chronic respiratory diseases. Adapted from GBD 2015 
Chronic Respiratory Disease Collaborators, Lancet (2017).1 
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Obstructive lung disease also presents a significant health care burden in Ontario and across 
Canada.  In 2011, the total provincial healthcare costs of COPD and asthma were $1.8 
billion and $3.9 billion respectively.2  A significant portion of the health care costs from 
obstructive lung disease are related to exacerbations, or acute worsening of symptoms in 
asthma or in COPD patients.  Exacerbations may lead to patients seeking emergency room 
care, or being admitted to the hospital.  The health care cost of an exacerbation is variable, 
but hospitalization is known to contribute the most to exacerbation costs.3  As such, 
hospitalization is a very important metric to monitor when assessing management of COPD 
in the Canadian health care system.  Across Canada, COPD was the leading cause of 
hospitalization (except for childbirth) in 2015 and admitted patients remained in hospital 
for over a week on average.4  A 2008 study found that the average cost of a hospital stay 
for a COPD exacerbation was nearly $10 000 per patient, with the total cost of COPD 
hospitalizations estimated to be $1.5 billion per year.5  Poorly controlled asthma also leads 
to high healthcare costs, in particular through emergency department (ED) visits.  A recent 
survey showed that 93% of Canadians do not have their asthma under control,6 and asthma 
attacks were the cause of over 70,000 ED visits in 2015.7  These ED visits and admissions 
to hospital are large contributors to the economic burden of obstructive lung disease.  This 
overwhelming economic and health care burden reflect limitations in the treatment and 
management of obstructive lung disease.   In part, this is due to our limited understanding 
of the mechanisms leading to ventilation heterogeneity in these patients, and how these 
mechanisms are related to patient outcomes.   
Obstructive lung disease is characterized by airflow obstruction that is clinically evaluated 
using measures of airflow taken at the mouth.8  Unfortunately, these airflow measurements 
are known to correlate weakly with patient outcomes9 in part because they are global 
measures of a heterogeneous disease, and in part because they are not sensitive to changes 
in the periphery of the lung.  The forced oscillation technique (FOT) evaluates the 
biomechanical properties of the lung by applying a multi-frequency pressure wave at the 
mouth during passive breathing.10  This technique is easily and inexpensively applied in a 
clinical setting and can provide information about obstruction in the lung periphery, 
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making it a very promising tool to improve clinical evaluation and, hopefully, management 
of disease.   
Pulmonary imaging tools are used clinically and in research to image lung structure and 
function in obstructive lung disease.  Using inhaled hyperpolarized 3He MRI, researchers 
capture spatial ventilation information and quantify ventilation abnormalities that are 
known to be related to disease severity11, 12 and control.13  However, the structural 
determinants of these abnormalities are not yet fully understood.14  Imaging measurements 
of ventilation can be combined with measurements using other techniques (such as FOT) 
to study structure-function relationships more deeply.   
Computational models are used to study biomechanical properties of the lung and the 
relationships between lung structure and function.15-17  Modeling studies are advantageous 
in that they allow the researcher to specify the parameters of the system, and predict the 
function of the system based on these known parameters.  Researchers are then able to 
study with high precision how the model responds to a known input.  Computational 
modeling has been used to study the effects of the number, severity and spatial distribution 
of airway closure on respiratory system impedance.  Recent studies have used functional 
imaging data to guide the spatial distribution of ventilation abnormalities, and studied how 
this is reflected by structural changes to the model.18, 19  If biomechanical measurements 
are acquired using FOT in these same patients, the measured impedance can be compared 
to model predictions.  Unfortunately, only one small study to date has combined functional 
pulmonary imaging, FOT, and biomechanical modeling in asthma.20  Accordingly, there is 
a need for larger studies that combine these three modalities to more deeply study structure-
function relationships in obstructive lung disease.21, 22 
This thesis focuses on the application of FOT, pulmonary MRI and computational lung 
modeling in asthma and COPD.  This chapter provides the background knowledge relevant 
the original research presented in Chapter 2.  It begins with an overview of the respiratory 
system’s structure and function and the biomechanical processes behind normal respiration 
(1.2), followed by the pathophysiology of obstructive lung disease (1.3).  The established 
clinical measurements of lung function are addressed next (1.4) followed by a discussion 
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of FOT as an emerging clinical tool (1.5) and current structural and functional pulmonary 
imaging techniques used in clinic and research (1.6).  The final tool to be introduced is 
biomechanical modeling (1.7).  Finally, the specific hypotheses and objectives of this thesis 
are introduced (1.8). 
1.2 Lung Structure, Function, and Biomechanics 
The respiratory system is a complex biomechanical system that serves primarily to deliver 
oxygenated gas to the bloodstream and to remove carbon dioxide.  The system is composed 
of the oral and nasal cavities, the lungs (bronchi, bronchioles, alveolar ducts and alveoli), 
the diaphragm and the chest wall.  The lungs themselves are composed of many soft tissue 
components including the airways, parenchymal tissue and vasculature.23  These structures 
function together to bring oxygenated gas through the airways into the alveoli to participate 
in gas exchange and then expel the carbon-dioxide rich gas to the surroundings. This 
section will outline in detail the structures involved in this process, and how they function 
as part of this system.    
1.2.1 The Conducting Airways 
From the oral and nasal cavities, gas travels through a series of branching airways as it is 
carried into the lungs.  The entire branching structure is shown in Figure 1-2.  From the 
mouth gas first reaches the trachea, a large hollow tube with cartilage rings for structural 
support. The trachea branches to form the two main bronchi, which are also supported by 
cartilage and feed the left and right lungs.  Once in the lungs, these main bronchi continue 
an asymmetrical dichotomous branching pattern.  The bronchi, which transport gas 
throughout the lung, decrease in diameter as they branch while growing geometrically in 
number.  After approximately four branching generations, these bronchi branch into 
bronchioles.  Bronchioles are structurally different from bronchi in that they are no longer 
structurally supported by cartilage.  Instead, these small airways are tethered to the 
surrounding parenchymal tissue for support.  The airway walls of the bronchi are made of 
soft tissue, blood vessels and smooth muscle fibres which are wrapped circumferentially 
around the airway to control airway diameter.23  Bronchioles continue the same branching 
pattern as the bronchi for approximately 16 branching generations.  The airways from the 
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trachea to the terminal bronchioles are collectively called the conducting zone of the lung 
as their primary function is to conduct gas from the environment to the alveoli for gas 
exchange.  In these airways, airflow is restricted by the airway diameter and is well 
described by Womersley flow as described in Section 1.7.2.  It should be noted that the 
conducting airways are larger in diameter, but there are far fewer of them than small 
peripheral airways.  As a result, the total cross-sectional diameter is smaller and the 
resistance to airflow is much larger in the conducting airways than in the peripheral 
airways.  The terminal airway resistance is negligible in comparison, and therefore does 
not contribute to traditional measurements of airflow at the mouth which are discussed in 
Section 1.4.1.   
1.2.2 The Peripheral Airways and Alveoli 
The peripheral airways begin at the bronchioles and after approximately 16 branching 
generations, the terminal bronchioles branch into the respiratory bronchioles.  This marks 
the start of the respiratory zone, so called because this is the generation at which alveoli 
are present and gas exchange starts to occur.23  The respiratory zone makes up the final 7 
generations of the airway tree.  As shown in Figure 1-2, the respiratory bronchioles branch 
into the alveolar ducts, which are smaller in diameter and are surrounded by more alveoli.  
The ducts then branch into the terminal airways, called the alveolar sacs.  The alveolar sacs 
are approximately 0.2mm in diameter, and are surrounded completely by alveoli to 
maximize the surface area available for gas exchange.  The airways in the respiratory zone 
have a very small diameter, but there are many more of them than in earlier branching 
generations.  As a result, they have a very large cross-sectional area and gas travels through 
them by diffusion rather than flow.   
Alveoli are small sac structures, approximately 300µm in diameter.23  They line the 
terminal airways in clusters, maximizing the surface area that is available for gas exchange.  
While these structures are very small, there are approximately 480 million alveoli in the 
average adult lung,24 creating a very large functional surface area of approximately 85 
square metres.23  Alveoli do not have any supporting muscle tissue, but are also tethered to 
the surrounding parenchymal tissue for structural support.  They are extremely thin (0.2-
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0.3µm)23 in order to maximize diffusion of oxygen and carbon dioxide between the alveoli 
and the surrounding capillaries.   
Due to the dichotomous branching structure of the airway tree, 50% of the total lung 
resistance originates from the large, central airways and only 10% of the resistance from 
the small airways (i.e., <2 mm in diameter). In passive breathing, the remaining 40% of the 
resistance derives from the mechanical properties of the lung tissue.25  For this reason, the 
peripheral airways are referred to as the ‘quiet’26 or ‘silent’27 zone, referring to the fact that 
COPD is known to originate in the small airways and terminal airspaces28 but these early 
stages are not reflected in clinical measurements such as spirometry.  As a bulk airflow 
measurement, spirometry is largely sensitive to the central airways that contribute the most 
resistance and relatively insensitive to changes in the small airways.   
 
Figure 1-2 Schematic of the Human Airway Tree 
The conducting airways are made up of the first 16 generations of branching airways, and 
are responsible for conducting gas to the alveoli for gas exchange.  The final 7 branching 
generations make up the respiratory zone, and are lined with alveoli for gas exchange.   
Adapted from West, JB, Respiratory Physiology: The Essentials, Ninth Edition.23 and 
Lumb, AB, Nunn’s Applied Respiratory Physiology.29 
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1.2.3 Ventilation 
Ventilation is the flow of gas into (or out of) the lungs, achieved by the biomechanical 
process of breathing.  This complex process occurs by action of the intercostal muscles, 
abdominal muscles and the diaphragm.  To inhale, these muscles all contract, bringing the 
diaphragm down and the ribs outward.  This motion decreases the pressure in the thoracic 
cavity, causing gas to flow inward through the airways.23  As previously mentioned, the 
motion of the gas is best described by flow in the conducting airways, and by diffusion in 
the respiratory bronchioles and alveolar ducts where the combined cross-sectional area is 
very large.  Airflow mechanics in the airways will be discussed in detail in Section 1.7.2.  
Once the oxygenated gas reaches the alveoli, gas exchange occurs; oxygen diffuses into 
the capillaries through the thin membrane of the airway wall and carbon dioxide 
simultaneously diffuses out of the blood and into the alveoli.  Expiration is a passive 
manoeuvre, during which the intercostal muscles, abdominal muscles and diaphragm relax.  
Recoil forces in the lung cause the diaphragm to rise and the ribs contract, causing the 
pressure in the thoracic cavity to increase and gas to flow back out of the lungs through the 
airways, carrying with it the carbon dioxide to be removed from the body.23  It is important 
to note that ventilation and gas exchange are dependent on both the central and peripheral 
airways.  If any obstruction causes resistance in the airways to increase, the same pressure 
differential will produce a lower rate of airflow, impeding the lung in performing its 
functional task. 
1.3 Pathophysiology of Obstructive Lung Disease 
Obstructive lung disease is characterized by persistent airflow limitation measured at the 
mouth.  Importantly, the obstruction to airflow is not uniformly distributed throughout the 
lungs but rather, it is heterogeneous.  Airflow obstruction can be caused by changes in the 
airway lumen, the airway wall or the peribronchial region, leading to the ventilation 
heterogeneity that is characteristic of obstructive lung disease.  This thesis will focus on 
the two dominant forms of obstructive lung disease: asthma and COPD. 
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1.3.1 Asthma 
Asthma is a chronic respiratory condition characterized by variable airflow limitation 
accompanied by shortness of breath, wheeze and a feeling of tightness in the chest;30 these 
symptoms are usually reversible using an inhaled bronchodilator.  Asthma can begin in 
childhood or adulthood, and affects many people throughout their adult lives.  Airflow 
limitation in asthma is caused by narrowing of the airway lumen due to increased smooth 
muscle responsiveness, inflammation, and abnormal mucus production as illustrated in 
Figure 3.31  This narrowing has been observed in both the central and peripheral airways 
in histopathological studies.32  Airway inflammation is a multi-cellular process, but is 
characterized by eosinophils in asthma. The increased presence eosinophils in the airway 
walls promotes airway constriction, increasing the effect of smooth muscle constriction 
and decreasing the tethering forces of the parenchyma.33  Increased smooth muscle mass 
in the airways is common in asthma and also contributes to thickening of the airway wall 
and narrowing of the lumen.  Often the airway smooth muscle is hyperresponsive, meaning 
it excessively constricts in response to stimuli, causing severe airway narrowing and 
increased resistance to airflow.  These cases of sudden acute airway obstruction are referred 
to as an asthma attack.   
1.3.2 COPD 
Chronic obstructive pulmonary disease (COPD) is characterized by chronic airflow 
obstruction that cannot be reversed using a bronchodilator.  COPD develops over a 
patient’s life as a result of exposure to cigarette smoke (the primary risk factor for COPD),34 
environmental irritants, or due to genetic conditions such as alpha-1 antitrypsin 
deficiency.35  Exposure to these factors causes an inflammatory response in the small 
airways and alveoli that is associated with the destruction of alveolar tissue over time.  This 
process leads to airflow limitations due to a loss of elastic recoil in the lung tissue,36, 37 
small airway collapse due to loss of parenchymal tethering31 and inflammation in the small 
airways.  Obstruction can also occur in the small airways as a result of excessive mucous 
production, as illustrated in Figure 3.  
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Figure 1-3: Small Airway Pathology in Asthma and COPD 
Small airway changes from a healthy lung (left) to asthma (middle) and COPD (right). In 
asthma, thickening and contraction of the smooth muscle (A), as well as inflammation and 
thickening of the airway wall (B) contribute to airway narrowing (C).  In COPD, there is 
inflammation and thickening of the airway wall (B), as well as an accumulation of excess 
mucus in the lumen (D).  Adapted from Hogg JC, Lancet (2004)38 and Saetta M et al. Eur 
Respir J (2001).33 
 
The severity of airflow obstruction as measured by spirometry (described in detail in 
Section 1.4.1) has been standardized and is used to classify COPD subjects into four 
severity grades39 as shown in Table 1-1. 
Table 1-1: GOLD COPD Severity Grade 
If FEV1/FVC < 70%: 
GOLD I  Mild FEV1 > 80%pred 
GOLD II  Moderate 50% ≤ FEV1 > 80%pred 
GOLD III  Severe 30% ≤ FEV1 > 50%pred 
GOLD IV  Very Severe FEV1 < 30%pred 
FEV1: forced expiratory volume in 1 second; FVC: forced vital capacity 
1.4 Clinical Measurements of Lung Function 
Clinically, there are several tests used to evaluate a patient’s lung function for diagnosis or 
monitoring of obstructive lung disease.  Physicians primarily rely on pulmonary function 
tests (PFTs) to evaluate lung function in the clinic.  These tests involve a variety of 
breathing manoeuvers and measurements made at the mouth that provide information about 
 10 
 
how the lungs are functioning as a whole. This section introduces spirometry, 
plethysmography, diffusing capacity of the lung for carbon monoxide and clinical 
questionnaires used to measure disease control and quality of life.  Measurements of 
volume and airflow are often presented as a percent of the predicted value (%pred) based on 
the patient’s age, sex, height, and ethnicity.40  
1.4.1 Spirometry 
Spirometry can be performed using a handheld spirometer like the one shown on the left 
in Figure 1-4.  To perform spirometry, the patient wears nose plugs and begins by breathing 
normally into the mouthpiece.  After approximately 4 normal breaths, the patient is asked 
to fully inhale until they reach total lung capacity.  Then, they sharply and forcefully exhale 
using maximum effort, and continue to exhale until they cannot expel any more air.8  Gas 
volume and flow are measured using the spirometer throughout this test, and a 
representative volume-time curve is shown on the right in Figure 1-4.  Two measurements 
are derived from this manoeuver: the forced expiratory volume in 1 second (FEV1), which 
is the maximum volume of gas that can be expired in the first second of expiration; and the 
forced vital capacity (FVC), which is the total volume of gas that the patient can expire 
from full inspiration.8   
 
Figure 1-4 Pulmonary Function Testing: Spirometry 
Above is a handheld spirometer used to conduct spirometry (left) and the resulting volume-
time curve that is used to determine FEV1 and FVC (right).  
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1.4.2 Plethysmography 
Plethysmography is a technique used to measure lung volumes using Boyle’s law.41  In a 
seated position inside a sealed chamber, the patient is asked to perform a series of breathing 
manoeuvres including tidal breathing, full inspiration, and full expiration.  Pressure is 
measured in the chamber throughout this test, while the volume of the sealed chamber is 
constant.  The lung volumes are calculated from these measurements using Boyle’s law.  
The volume-time curve from this test and the measured lung volumes are illustrated in 
Figure 1-5. The volumes of interest that are calculated from this test are: functional residual 
capacity (FRC), inspiratory capacity (IC), tidal volume (TV), residual volume (RV), vital 
capacity (VC) and total lung capacity (TLC).41  FRC is the remaining volume in the lungs 
after a normal exhalation, IC is the maximum volume of gas that can be inhaled from FRC, 
TV is the volume of gas inhaled/exhaled during tidal breathing, RV is the volume of gas 
remaining in the lungs after maximum exhalation, VC is the volume of gas between total 
inspiration and total expiration and TLC is the maximum volume of the lungs at full 
inspiration.41   
 
 
Figure 1-5 Pulmonary Function Testing: Plethysmography 
Above is a whole body plethysmograph (left) and a sample volume-time curve used to 
determine lung volumes (right). 
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1.4.3 Diffusing Capacity of the Lung 
The diffusing capacity of the lung for carbon monoxide (DLCO) is used to evaluate 
pulmonary function for patients with emphysema.42  The test is used to determine the extent 
to which the destruction of alveolar tissue has reduced the capacity for oxygen to diffuse 
into the bloodstream.  To perform this test, the patient exhales to RV and inhales a 
specialized test gas containing a low concentration of CO (0.3%) to TLC.  The patient then 
holds their breath for 8 seconds, allowing the CO to diffuse into the bloodstream, and 
exhales through the mouthpiece.  The concentration of CO in the exhaled gas is measured, 
and compared to the known concentration in the inhaled gas to determine how much 
diffused into the blood.42   
1.4.4 Disease Control and Quality of Life 
Asthma control is measured using the Asthma Control Questionnaire (ACQ),43 and quality 
of life is measured using the Asthma Quality of Life Questionnaire (AQLQ).44  The ACQ 
is designed to collect information about how patients perceive their symptoms, how their 
symptoms limit their activities and how often they rely on a bronchodilator.  It is designed 
to determine if a patient is achieving the primary goal of asthma treatment- control of the 
disease.  The AQLQ asks more specific questions regarding symptoms and how a patient 
feels about them.  It evaluates how specific symptoms may affect the activities in the 
patient’s day to day life in order to quantify patient health-related quality of life. 
In COPD, quality of life is measured using the St. George’s Respiratory Questionnaire 
(SGRQ).45  This single questionnaire collects information about patient symptoms, 
activity, and impacts on daily life.  From the complete questionnaire, scores are calculated 
for each component, as well as an overall score.  The ACQ, AQLQ and SGRQ were 
developed as sensitive standardized methods to quantify quality of life for patients with 
asthma or COPD for use in scientific studies or clinical care. 
1.4.5 Obstructive Lung Disease 
The tests described above are all sensitive to the pathology of obstructive lung disease 
described in Section 1.3.  Spirometry measurements such as FEV1 and FVC are reduced in 
 13 
 
obstructive lung disease due to airway obstruction and early airway closure in expiration.  
This leads to an increase in RV and TLC due to premature airway closure and, in COPD, 
loss of elastic recoil.  COPD patients also have decreased DLCO as a result of alveolar 
destruction.   
1.5 Emerging Clinical Measurements of Lung Function 
1.5.1 Mechanical Properties of the Lung 
As previously described, the respiratory system functions through the mechanical 
expansion and contraction of the thoracic cavity which causes oscillations in the pressure 
inside, resulting in flow through the airways, or ventilation.  In order to better understand 
the process of ventilation, one must understand the relationships between oscillations of 
pressure and airflow in the lung.  
The respiratory system can be modeled as a linear dynamic system, which means that it is 
described by linear differential equations and it evolves in time.  This is explained in greater 
detail in Section 1.7.  Pressure (P) and flow (the time-derivative of volume, V) are related 
by a quantity called respiratory system impedance (Zrs).46  Impedance is a complex value, 
as it describes the relationship for both amplitude and phase between P and V as shown in 
the linear differential equation below (Equation 1.1). 
	 𝑃(𝑓) = 	𝑍)*(𝑓)𝑉(𝑓)	 (1.1)	
The real and imaginary components of impedance are called the respiratory system 
resistance (Rrs) and reactance (Xrs), respectively, as expressed in Equation 1.2.   
	 𝑍)*(𝑓) = 	𝑅)*(𝑓) + 𝑖𝑋)*(𝑓)	 (1.2)	
Rrs and Xrs are intrinsic properties of the system that affect how the system responds to 
input.  Rrs is related to airway lumen calibre; as airways narrow their resistance to airflow 
increases.46  This can occur in obstructive lung disease as a result of inflammation, smooth 
muscle constriction, or excessive mucus production as explained in Section 1.3.  Xrs is 
related to elastic properties of the tissue, although the exact property being measured is 
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dependent on the frequency at which the measurement is made.  At low frequencies, Xrs 
has a negative value and reflects elastic reactance.  At the resonant frequency, where Xrs is 
equal to zero, (fres < 10Hz for a healthy adult) the elastic and inertial forces are equal and 
opposite, and pressure and airflow are perfectly in phase.  For f > fres, Xrs is positive and 
reflects the inertial reactance of the tissue.10, 47  Inflammatory processes that occur in both 
asthma and COPD can decrease the elasticity of lung tissue, and this change is measured 
by Xrs.   
In obstructive lung disease, both resistance and reactance of the respiratory system are 
increased.  Resistance increases as a result of airway obstruction, and the frequency 
dependence of resistance increases with heterogeneous obstruction.  Reactance is increased 
due to inflammation in the airways and surrounding tissue, which decreases tissue 
elasticity.  In order to measure these changes in the mechanical properties of the lung in 
obstructive lung disease, one must measure the pressure and flow of gas in the lungs at 
some known frequency.  One way to do this is to apply a pressure wave (at one or many 
frequencies) at the mouth, and measure pressure and airflow in response to this input.  This 
method is known as the forced oscillation technique (FOT).   
1.5.2 The Forced Oscillation Technique 
The application of pressure oscillations to probe the mechanical properties of the lung 
originated with Dubois et al. over sixty years ago.48  Since this study, forced oscillations 
have been used widely in research, and clinical technology has been developed for the use 
of FOT.  Typically for this technique, a multi-frequency pressure waveform is applied at 
the mouth.  In this thesis, I will focus on the use of frequencies from 5Hz to 37Hz.  In 
Figure 1-6, a commercialized FOT device is shown that operates in this frequency range 
(Tremoflow, Thorasys, Montreal CA).  To acquire a measurement, the patient supports the 
soft tissue of their cheeks and chin with their hands to minimize the contribution of the 
upper airways.  The patient breathes normally into the mouthpiece while a multi-frequency 
pressure oscillation is applied by the device for approximately 10 seconds.  The FOT device 
measures the pressure and airflow in response to this stimulation to calculate Rrs and Xrs at 
each frequency.   
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Previous studies have investigated the frequency dependence of this signal and found that 
low-frequency oscillations probe the entire airway tree, while the higher frequency 
oscillations are damped out in the mid-range airways and are therefore not able to probe 
the small airways.47, 49  Based on these studies, specific frequencies have been identified 
for clinically relevant measurements; 5Hz is a low frequency known to probe the entire 
airway tree (including the small airways) and 19Hz is a high frequency oscillation that is 
known to probe the large airways, and is dampened out before reaching the small airways.  
This means that FOT can be used to measure the impedance related to the small airways in 
particular as shown in Equation 1.3, an important feature not present in many other PFTs.   
	 𝑅*0122 = 	𝑅)* 5 − 19𝐻𝑧 = 𝑅)* 5𝐻𝑧 − 𝑅)*(19𝐻𝑧)	 (1.3)	
As described in Equation 1.3, the frequency dependence of the FOT impedance signal can 
be used to identify the region in which resistance is elevated, in the central or peripheral 
airways as illustrated in Figure 1-6.  FOT has been used extensively to study various forms 
of lung disease including both obstructive and restrictive diseases, and while it is not able 
to distinguish between obstructive and restrictive disease,10 it is able to determine severity 
within obstructive lung disease.50, 51  
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Figure 1-6 Frequency Dependence of the Forced Oscillation Technique 
A multi-frequency pressure wave is produced and travels through the airways during 
passive breathing. The low-frequency component (5Hz) is able to travel through the entire 
airway tree, while the high-frequency component (19Hz) is damped out before reaching 
the peripheral airways. 
1.6 Imaging Measurements of Lung Structure and Function 
While PFTs provide measurements of lung function that are easily integrated into clinical 
workflows, they are limited by their global nature.  As discussed in Section 1.2.2, global 
measures such as spirometry are not sensitive to changes in the small airways because they 
contribute little to the overall resistance of the respiratory system.  While FOT is sensitive 
to the differences between central and peripheral airways, it is still not able to provide 
specific spatial information.  Pulmonary imaging has been developed to provide structural 
and functional information with high spatial and temporal resolution, providing a wealth 
of additional information about the regions of the lung that are affected by disease.  
Pulmonary imaging is also used in a variety of ways to study lung biomechanics, as is 
discussed in depth in Appendix D.  The anatomical and functional imaging methods 
discussed in this thesis include planar x-ray, computed tomography (CT), single photon 
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emission computed tomography (SPECT), positron emission tomography (PET) and 
magnetic resonance imaging (MRI).    
1.6.1 Structural and Anatomical Imaging 
Anatomical imaging is used to generate high-resolution structural images of the respiratory 
system in order to identify anatomical changes that occur in lung disease.  These changes 
may include changes to the airway structure, or changes to the density of the parenchymal 
tissue.  These changes are primarily measured using planar or CT x-ray imaging, but can 
also be measured using MRI.   
X-ray Imaging 
Planar x-ray imaging is the earliest developed and most common type of imaging acquired 
in lung disease.  X-rays were discovered by Wilhelm Röntgen in 1895, when he famously 
captured an x-ray image of his wife’s hand.  It is still widely used for chest and lung 
imaging because it is inexpensive, and requires a low radiation dose to acquire (0.01 
mSv).52  To generate these images, a cone-shaped beam of x-rays is directed at the patient’s 
chest.  Some of these x-rays will be absorbed by the body, and some will travel through 
the body and reach a detector on the other side which absorbs and measures them.  The 
number of absorbed (or attenuated) x-rays is dependent on the electron density of the tissue.  
For example, bones have high density and appear bright in an x-ray image, while gas inside 
the lungs has very low density and appears very dark in an x-ray image.  X-ray images can 
be used to detect changes in the shape of the lungs (indicative of gas trapping or 
emphysema)53 or structural changes to the airways.  In severe emphysema, the decreased 
density of the parenchymal tissue is also visible as a darker region in the image.54  Planar 
x-ray imaging is limited because it is a 2D projection of all the structures in the thoracic 
cavity, making it difficult to localize abnormalities.  This limitation was addressed by the 
development of 3-dimensional x-ray computed tomography (CT) imaging.   
Computed Tomography 
CT imaging was developed in the 1970s to generate 3-dimensional medical images.  The 
3D volume is computed from many x-ray images collected at different angles around the 
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patient.  The patient is positioned supine on the CT scanner bed, and passes through a 
donut-shaped scanner containing an x-ray source and a detector array positioned opposite 
to it.  The source and detector rotate around the patient, collecting multiple planar x-ray 
images.  Using computational reconstruction techniques including filtered back projection 
and iterative reconstruction, these images can be reconstructed into a 3-dimensional 
volume image.55  Each voxel in the image is a measurement of the tissue density normalized 
to the density of water using Hounsfield units (HU)56 as shown below in Equation 1.4.   
	 𝐻𝑜𝑢𝑛𝑠𝑓𝑖𝑒𝑙𝑑	𝑈𝑛𝑖𝑡 = 𝜇CD**EF − 𝜇G1CF)𝜇G1CF) 1000	[𝐻𝑈]	 (1.4)	
Using CT imaging, much higher resolution and contrast images can be acquired than with 
planar x-ray alone.  CT can be used to visualize and measure various structural components 
of the lungs, and the structural changes that occur in lung disease.  Some of these structural 
features are shown in Figure 1-7.  For example, the voxel-wise density measured in the 
lung parenchyma can be used to identify healthy tissue and emphysematous tissue in 
COPD.  The value of -950 HU has been established to identify the threshold below which 
tissue has been subjected to destruction and is considered emphysematous (in an inspiration 
image).57  Using simple threshold methods, emphysematous tissue can be easily defined in 
an inspiration CT image in COPD.  This is quantified using the relative area of the density 
histogram below -950 HU (RA950).  Similarly, the -856 HU has been used as a threshold to 
identify trapped gas in an expiration image in either asthma or COPD and quantify it by 
the relative area below the density histogram below -856 HU (RA856).58  Emphysema, or 
airspace enlargement, are shown in representative CT images in Figure 1-7.   
Using specialized software (Pulmonary Workstation V.2.0. VIDA Diagnostics, Coralville, 
Iowa, USA) the airway tree can be segmented from a CT image, up to the 2mm airways.  
Representative airway trees for COPD and asthma are shown in Figure 1-7.  Using the 
segmented airway tree, the airway lumen and the airway wall thickness can be measured 
and compared to measurements derived from a healthy lung to determine the extent of 
airway narrowing.  For example, a recent study shown that there is increased heterogeneity 
in airway tone in asthma as compared to healthy subjects.59   
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Figure 1-7 Computed Tomography of COPD and Asthma 
Above are computed tomography (CT) images for COPD (top) and Asthma (bottom) with 
RA950 maps shown in yellow in the center and 3D renderings of the airway tree on the right.   
The radiation dose from a thoracic CT scan is approximately 7mSv, or approximately 2-3 
years of background radiation exposure.60  Recently, advancements in imaging technology 
have led to the development of low-dose and ultra-low dose acquisition procedures so that 
patients may one day have access to CT imaging with much lower radiation exposure.  
However, these techniques have not yet been clinically implemented and concerns remain 
about repeated CT imaging for patients with lung disease, especially for longitudinal 
monitoring.  In response to these concerns, there has been recent interest in advanced MRI 
acquisition methods to acquire structural images of the lung using MRI.    
Ultra-short Echo Time MRI 
Very low signal intensity is measured in the lung parenchyma with traditional MR methods 
in part because of the many air-tissue interfaces, which cause the transverse signal to decay 
very quickly (0.4-0.9ms).61, 62  In order to overcome this, the echo time (TE, the time 
between the RF excitation pulse and data acquisition) must be extremely short to acquire 
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signal from the parenchymal tissue before it decays.63, 64  Due to recent technological 
developments, TE of 0.03ms is now achievable and due to advanced image sampling and 
reconstruction techniques, UTE images of the entire lung volume can be acquired in a 
single breath-hold with minimal motion artifacts.65  UTE MR signal intensity is correlated 
with tissue density in COPD65 and asthma,66 and may be related to structural changes such 
as emphysema. 
1.6.2 Functional Imaging 
The primary function of the lung is ventilation; the delivery of oxygenated gas to the alveoli 
throughout the lung and the removal of carbon dioxide.23  In order to generate functional 
images of the lung, one must be able to image the distribution of inhaled gas.  In the last 
three decades, several techniques have been developed to acquire functional images of the 
lung using both contrast-enhanced and non-contrast enhanced methods.   
Non-Contrast Enhanced Functional Imaging 
Indirect measurements of lung function can be gathered from the changes in tissue density 
or tissue deformation measured using structural imaging.  This can be done by acquiring 
structural CT or MR images at multiple lung volumes, including full inspiration and full 
expiration.  Using deformable registration techniques, these images can be co-registered 
and by using the deformation field,67 or the voxel-wise changes in tissue density,68 the 
voxel-wise change in gas volume can be calculated as a surrogate measure of ventilation.69  
Using this technique, researchers are also able to use the deformation of the lung tissue to 
study its biomechanical properties.  This technique is the earliest application of medical 
imaging to study breathing and lung mechanics70, 71  and is discussed in further detail in 
Appendix D.  
Another non-contrast enhanced method for functional imaging is Fourier Decomposition 
(FD) MRI.  This technique, which has been developed over the past decade, is implemented 
by acquiring a time series of 1H MR images during tidal breathing.  These images are non-
rigidly co-registered, and represented as a voxel-wise time series of signal intensity values.  
The Fourier Transform is applied to each time series, and by measuring the amplitude of 
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the Fourier signal at the breathing frequency, one obtains the amplitude of the change in 
tissue density due to breathing.72  Similar to multi-volume CT methods, this method 
provides a surrogate measure of ventilation but does not subject patients to any ionizing 
radiation exposure.  This has been applied in COPD73 and asthma74 and is correlated with 
hyperpolarized gas MRI ventilation, which will be described in Section 1.6.3.  
Contrast-Enhanced Functional Imaging 
Ventilation can also be directly imaged using inhaled contrast agents.  This technique has 
been applied using many modalities, including MRI and nuclear imaging techniques such 
as single photon emission computed tomography (SPECT) and positron emission 
tomography (PET). In SPECT, patients inhale a radioactive tracer gas that emits a high 
energy photon (gamma ray) when it decays.  The emitted photons are collected at multiple 
angles around the patient and used to reconstruct the spatial distribution of the gas; this has 
been applied to study ventilation in obstructive lung disease.75-78  In PET, the tracer 
produces two simultaneous photons travelling antiparallel to each other that can also be 
used to reconstruct the spatial distribution of the inhaled tracer.17, 79  These methods are 
limited by the patient exposure to ionizing radiation, low spatial resolution and dependence 
on a cyclotron for isotope production.  This renders them inappropriate for some 
applications in obstructive lung disease, such as longitudinal monitoring.   
1.6.3 Inhaled Noble Gas Magnetic Resonance Imaging 
MRI is a promising technique for imaging lung function as it does not involve any exposure 
to ionizing radiation, and is therefore suitable for longitudinal studies.  However, MR 
imaging techniques are limited by the low proton density and many tissue-air interfaces in 
the lung that lead to extremely low MR signal in the parenchyma.  Inhaled noble gas MRI 
addresses this limitation by directly imaging the gas that is inhaled by the patient, rather 
than imaging the lung tissue.  To acquire these images, the patient inhales a known volume 
of hyperpolarized noble gas (approximately 5mL/kg body weight) and holds their breath 
for approximately 10-16 seconds while the image of the gas distribution is acquired.  These 
images are co-registered to anatomical MR images in order to identify the regions of the 
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patient’s lungs that are ventilated and, more importantly, the regions that are poorly 
ventilated.   
Hyperpolarization 
Hyperpolarized noble gas imaging is currently performed using one of two gases, helium-
3 (3He) and xenon-129 (129Xe). The first hyperpolarized gas image of the lung was 
generated in 1994 using 129Xe,80 and was shortly followed by images using 3He.81  3He was 
initially preferred for imaging due to the high signal-to-noise ratio that could be achieved.  
However, due to the limited supply and increasing price of 3He,82 there has been renewed 
interest in 129Xe for ventilation imaging in the future.   
An optical spin-exchange system is used to achieve hyperpolarization of a noble gas.  A 
circularly polarized laser at the wavelength corresponding to the electronic orbital 
transition energy of rubidium (Rb) is used to excite electrons of vaporized Rb (or another 
alkali metal).  The excited Rb vapor is contained in an optical cell that is also filled with 
3He/129Xe.  The Rb and 3He/129Xe atoms collide and by a process called the spin-spin 
interaction, angular momentum is transferred into the 3He/129Xe atom.  This increases the 
nuclear polarization of the unpaired nuclear proton.  The optical cell is maintained in a 
constant magnetic field so the polarized atoms will decay much more slowly to their ground 
state.  As collisions continue to occur, up to 45% of the gas can be polarized; at this point 
it is considered hyperpolarized.  This hyperpolarized gas has four orders of magnitude 
greater polarization than at thermal equilibrium (thermal polarization in a 3.0 Tesla 
magnetic field ≈ 10-5).83, 84   
Ventilation Imaging 
For the acquisition of ventilation images, the patient inhales a 1.0L volume of gas 
(approximately 25% hyperpolarized noble gas, 75% ultra-high purity nitrogen gas) while 
lying supine, and holds their breath for approximately 10-16 seconds as the image is 
acquired.85  The inhaled gas travels to all ventilated regions of the lung within this single 
breath hold, so in a healthy subject the ventilation is uniformly distributed throughout the 
lungs.  However, in poorly ventilated regions of the lung there are dark voids in the 
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ventilation image because very little hyperpolarized gas was able to enter.85, 86  These 
regions are called ventilation defects, and are shown in Figure 1-8 below. 
 
Figure 1-8 3He Ventilation MRI of COPD and Asthma 
Ventilation MRI of a healthy volunteer, a subject with COPD and an asthmatic subject.  
Hyperpolarized 3He MRI gas distribution (in cyan) is co-registered to 1H MRI of the thorax 
(in grey-scale). Dark regions in the image indicate ventilation defects. 
As shown by the ventilation defects in Figure 1-8, the distribution of hyperpolarized gas is 
heterogeneous in patients with obstructive lung disease.  In order to quantify these defects, 
the ventilation images are segmented and co-registered with the anatomical proton image.  
A k-means clustering algorithm is used to bin the ventilation into five clusters87 such that 
the lowest ventilation cluster corresponds to the background signal intensity, and is used 
to identify ventilation defects.  In order to quantify the defects in the whole lung, the 
ventilation defect volume (VDV) is normalized to the thoracic cavity volume (TCV); this 
measurement is called the ventilation defect percent (VDP) and is shown in Equation 1.5 
below.  
	 𝑉𝐷𝑃 = 𝑉𝐷𝑉𝑇𝐶𝑉 ×100%	 (1.5)	
This measurement has been used to quantify ventilation heterogeneity in a variety of lung 
diseases, including asthma14 and COPD.88  The structural determinants of ventilation 
defects and their clinical consequences are still not fully understood,14 and studies of these 
are ongoing.  In asthma, recent work has shown that ventilation defects are related asthma 
control,13 and are spatially related to remodeled airways.14  In COPD, defects have been 
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shown to be related to exacerbations,89 and represent a mixed airways disease-emphysema 
phenotype.90  Hyperpolarized gas MRI has also been used to show treatment response in 
obstructive lung disease.91, 92  Together, these studies strongly suggest that ventilation 
heterogeneity measured by MRI is related to disease of the airways and airspaces.  In order 
to gain a deeper understanding of the small-scale structural changes associated with MRI 
ventilation defects, multi-modality studies are needed to probe ventilation heterogeneity 
and changes to the small airways, such as combining FOT measurements of small-airways 
resistance and MRI.   
1.7 Biomechanical Modeling of the Lung 
“A mathematical model is a set of equations that serve both as a precise statement of our 
assumptions about how the lung works mechanically and as a means of exploring the 
consequences of those assumptions.” Bates 2009.46 
As detailed in the previous sections, we can acquire a variety of functional and structural 
measurements that reflect changes to the lung tissue occurring in obstructive lung disease.  
However, because the functional unit of the lung is so small (≈300µm),23 current techniques 
lack the spatial resolution to image and study them directly.  Therefore, the relationships 
between structural and functional changes occurring in the small airways and alveoli are 
unclear.  Biomechanical modeling of the lung is used to probe these relationships, and can 
be divided into two categories, inverse modeling and forward modeling.   
1.7.1 Inverse Modeling 
Inverse modeling refers to the process of constructing a model of a system from 
measurements of inputs and outputs of the system.  In the case of the lungs, this refers to 
using measurements of respiratory system pressure and airflow (function) to model the 
mechanical properties of the lung tissue (structure).  Due to the limited number of distinct 
functional measurements available, inverse models are simplified models that specify only 
a few parameters of the system’s structure.  However, a good inverse model is able to 
effectively describe the overall behaviour of the system.  The simplest model of the lungs 
is the linear single compartment model.  While many higher-order models have been 
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developed, the linear single compartment model provides a surprisingly robust model of 
lung mechanics.  Rather than two lungs composed of millions of airways and alveoli, this 
model is composed of a single elastic compartment supplied by a single conduit as shown 
in Figure 1-9. The compartment has some variable pressure (P) and volume (V), and there 
is some flow of gas (V) resulting from a pressure differential across the conduit (ΔP).  These 
variables are dependent on the elastic properties of the compartment (E), and the resistance 
of the conduit (R).   
 
Figure 1-9: Linear Single Compartment Model of the Lung 
The mechanical properties of the lung can be estimated by a single elastic compartment 
with elastance E, supplied by a tube with resistance R.  Pel is the pressure in the elastic 
compartment, and ΔP is the pressure difference across the tube.  V is the volume of gas in 
the compartment, and V is the airflow into the tube. Adapted from Bates et al. 2009.46 
A linear system is one in which the dependent variable varies linearly with the independent 
variable when all other parameters are held constant; in this case the two variables (pressure 
and volume) are related through a linear differential equation by a quantity called 
impedance.  This impedance is complex, and is composed of resistance and reactance 
(which is related to elastance, as shown in Equation 1.7 below) as discussed in Section 1.5.  
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In deriving the relationship between pressure and volume, we assume that when elastance 
(E) is constant, Pel and V vary linearly (ie. Pel = EV). Similarly, we assume that when 
resistance is constant, the relationship between ΔP and 𝑉 is linear (ie ΔP = R𝑉).  ΔP and 
Pel must be combined in order to calculate pressure for the entire system (Equation 1.6). 
	 𝑃CP(𝑡) = 	𝐸𝑉(𝑡) + 𝑅𝑉(𝑡) + 𝑃R(𝑡)	 (1.6)	
Where P0 is the offset pressure, to account for the fact that the transpulmonary pressure 
(Ptp) is non-zero when V and V are zero due to the pressure of the pleural space.93  This 
equation is sometimes referred to as ‘the equation of motion of the lung’, as it is the 
fundamental equation describing the relationship between pressure and volume in the linear 
single-compartment model of the lung.46  While this is not an exact description of the 
behaviour of the lung, it forms a good approximation that is used widely in studies of lung 
mechanics, including in this thesis.  To show this, we apply the Fourier Transform to 
Equation 1.6, giving Equation 1.7.   
	 𝑃 𝑓 = 𝑅 − 𝑖𝐸2𝜋𝑓 𝑉(𝑓)	 (1.7)	
The relationship between reactance and elastance is given in Equation 1.8. 
	 𝑋)* 𝑓 = 𝑖𝐸(𝑓)2𝜋𝑓 	 (1.8)	
Using Equations 1.1, 1.7, and 1.8 we recover the equation for respiratory system impedance 
defined in Equation 1.2 that used in FOT to calculate Rrs and Xrs. 
1.7.2 Forward Modeling 
Forward modeling, otherwise known as simulation, involves devising a model with set 
parameters, and using this model to predict the output of the system.  In other words, this 
approach requires making a set of assumptions about the parameters of the system 
(structure), and using these parameters to predict the system’s behaviour (function). In 
mechanical modeling of the lungs, computational airway tree models with many branching 
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generations and alveolar compartments are used to predict the pressure or airflow response 
to a known stimulus.94  These models often also account for the mechanical properties of 
the upper airways and the chest wall.  In most studies, airflow is described by Womersley 
flow95 as shown in Equation 1.7.   
	 𝑍1 𝑓 = 	 𝑖2𝑓𝜌1D)𝑙1𝑟1W 1 − 2𝐽Y 𝛼1 −𝑖𝛼1 −𝑖𝐽R 𝛼1 −𝑖 [Y	 (1.9)	
Where i is the unit imaginary number, f is the oscillation frequency in Hz, ρair is the density 
of air (1.16 kg/m3), la is the length and ra is the radius of the airway, J0 and J1 are the 
complex Bessel functions of order 0 and 1 respectively and αa is the Womersley number 
for the airway given by Equation 1.8: 
	 𝛼1 = 𝑟1 2𝜋𝜌1D)𝑓𝜇1D) 		 (1.10)	
Where µair is the dynamic viscosity of humid air at 37 degrees C (1.85 x 10-5 Pa.s).  Elastic 
properties of the parenchymal tissue are also accounted for in many modeling studies.  
Using these properties of elasticity and airflow, as well as many other parameters including 
chest wall compliance and upper airway shunt,96 the impedance of the computational 
system can be estimated.   
1.7.3 Pulmonary Imaging and Biomechanical Modeling 
Forward models have been well developed and widely used to study lung mechanics in the 
past two decades.  Anatomically accurate computational models with up to 26 branching 
airway generations94 are used to study lung mechanics under a variety of conditions.  There 
has recently been increasing interest in incorporating spatial functional information from 
pulmonary imaging into computational modeling in order to more deeply understand the 
relationships between ventilation defects observed in obstructive lung disease and 
structural changes in the lung.  By incorporating imaging functional data into modeling 
studies, researchers can evaluate the effects of various known distributions of mechanical 
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changes throughout the lung in order to probe these relationships.  This has previously been 
applied in asthma, in an effort to understand the distribution of large and small airway 
closures that are involved in generating ventilation defects.18, 97  The combination of 
functional imaging and computational modeling presents many opportunities to explore 
more deeply the relationships between structure and function in obstructive lung disease.   
1.8 Thesis Objectives and Hypotheses 
In this thesis, I assessed MRI-measured ventilation defect percent, respiratory system 
impedance measured by the forced oscillation technique (FOT), patient quality of life and 
model-predicted respiratory system impedance in 100 obstructive lung disease patients.  
My objective was to evaluate the relationships between FOT-measured impedance and 
MRI-measured ventilation heterogeneity, as well as clinical measurements of patient 
quality of life.  I also compared FOT-measured impedance and the values predicted using 
patient-specific airway tree models.  I hypothesized that FOT-measured respiratory system 
impedance would be related to MRI ventilation heterogeneity and patient quality of life in 
asthma and COPD. Additionally, I hypothesized that measured and predicted impedance 
would be significantly correlated in all subjects.   
In Chapter 3, an overview and summary of the important findings and conclusions of 
Chapter 2 is provided.  The study specific and general limitations of this study will be 
discussed and some potential solutions.  The thesis concludes with an outline of future 
studies that can build on the work presented in this thesis.  
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CHAPTER 2 
2 OSCILLOMETRY AND PULMONARY MRI OF 
VENTILATION HETEROGENEITY IN 
OBSTRUCTIVE LUNG DISEASE: RELATIONSHIP TO 
QUALITY OF LIFE AND DISEASE CONTROL 
To better understand the relationships between FOT-measured respiratory system 
impedance, MRI ventilation defects and patient quality of life, we evaluated 100 patients 
with obstructive lung disease using 3He MRI, FOT, and quality of life and control 
questionnaires.  
The contents of this chapter were submitted to the Journal of Applied Physiology.  HM 
Young, F Guo, RL Eddy, GN Maksym, G Parraga. Oscillometry and Pulmonary MRI of 
Ventilation Heterogeneity in Obstructive Lung Disease: Relationship to Quality of Life and 
Disease Control. J Appl Physiol (Submitted November 15 2017). 
2.1 Introduction 
Ventilation heterogeneity is a hallmark characteristic of obstructive lung diseases such as 
asthma1-4 and chronic obstructive pulmonary disease (COPD)5, 6 and is related to disease 
symptoms and control.3, 6-8  Ventilation heterogeneity can be measured using a variety of 
techniques including multiple breath gas washout methods9-11 and pulmonary imaging.12-
16  Despite decades of research that focused on the quantification and development of our 
understanding of causes and clinical implications of ventilation abnormalities, many 
patients with obstructive lung disease and ventilation heterogeneity still have poor disease 
control and quality of life.17-20  This may be due in part, to the fact that the complex 
structural and biomechanical changes underlying ventilation heterogeneity are still not 
fully understood,21-23 including those contributed by airway abnormalities. 
The forced oscillation technique (FOT), first developed over 50 years ago,24 non-invasively 
probes the mechanical properties of the respiratory system (respiratory system impedance, 
Zrs) during quiet breathing by applying multi-frequency pressure oscillations at the mouth. 
The measured impedance reflects both resistance (Rrs) and reactance (Xrs) and is acquired 
at multiple frequencies to ascertain the frequency dependence of Rrs, which is believed to 
be related to small airway dysfunction.25  FOT has been extensively used to study patients 
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with COPD26-28 and asthma27-31 including the measurement of responses to 
bronchoconstriction in asthma30 and to bronchodilation.27, 28, 31  Previous studies have 
shown that both Rrs and Xrs are sensitive to heterogeneous airway narrowing in asthma32, 
33 but the exact location of this airway narrowing could not be identified.  On the other 
hand, hyperpolarized 3He MRI ventilation imaging has been used to identify the spatial 
location of ventilation abnormalities (or heterogeneity) in patients with asthma16, 21, 34-36 
and COPD.37-40  MRI ventilation defects reflect the severity of airflow obstruction34, 41  and 
respond to provocation (in asthma)15, 36, 42 and treatment.16, 43-45  In addition, MRI-derived 
ventilation heterogeneity was recently shown to be uniquely predictive of asthma control12 
and COPD exacerbations46.   
Computational airway modelling has also been used to study the relationship between 
airway caliber and ventilation heterogeneity.  Using an anatomical computational airway 
tree model,47 the caliber of the airway lumen can be manipulated to study the effects on 
respiratory impedance or ventilation distribution.  In some of these studies, the results 
suggested that airway narrowing must occur throughout the entire airway tree and in a 
heterogeneous fashion in order to replicate the respiratory impedance observed in 
asthma.25, 48, 49  In particular, modeling studies that incorporated ventilation data derived 
from positron emission tomography (PET) in asthmatics showed that airway narrowing 
near ventilation defects was not sufficient to replicate the impedance measured in 
participants.25, 48  Moreover, narrowing of the small airways was required to simulate 
impedance values observed in patients, as narrowing of large airways alone was not 
sufficient.49  Other modelling studies showed that ventilation abnormalities were positively 
correlated with increased Rrs50 and that a large proportion of the small airways (over 75% 
in severe asthma) had to be narrowed in order for the model-predicted resistance and 
reactance to agree with measured values.51  A follow-up study used functional information 
derived from hyperpolarized 3He MRI in a model whereby airways that were spatially 
related to ventilation defects were narrowed to generate patient-specific predictions of 
impedance.52  Numerous studies have probed structure-function relationships in asthma 
using biomechanical models informed by 3He MRI,49, 52 PET25, 48 and single photon 
emission computed tomography (SPECT),14 but few have compared impedance predictions 
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to experimental FOT measurements in patients.  Some studies have acquired impedance 
measurements for incorporation in models48, 49, 53  and a single study in a small group of 
asthmatic patients combined image functional modelling for comparison with 
experimentally-measured impedance.14   
There is a clear need for multi-scale studies that combine functional lung imaging, 
computational airway models and experimental oscillometry measurements to provide a 
deeper understanding of the relationships between structure and function in obstructive 
lung disease. Ultimately, this should lead to an understanding of how disease control and 
quality of life can be improved in patients.54-57  Therefore, the objective of this work was 
to evaluate the relationships between ventilation heterogeneity measured using 
hyperpolarized 3He MRI and FOT, and to ascertain how these measures are related to 
disease control and quality of life in obstructive lung disease.  Our second objective was to 
use ventilation MRI to modify a computational airway tree model to generate patient-
specific predictions of respiratory impedance, and compare these predictions to FOT-
measured impedance.  We hypothesized that MRI ventilation defect percent (VDP) would 
be significantly related to FOT-measured respiratory impedance in patients with asthma 
and ex-smokers, and that both measurements would be related to quality of life and disease 
control in these patients. 
2.2 Materials and Methods 
2.2.1 Study Design 
All participants provided written informed consent to study protocols (NCT# 
NCT02351141, NCT02263794, NCT02279329) approved by the local research ethics 
board.  Participants between ages 18 to 70 years with a current diagnosis of asthma, and 
patients between ages 50 to 90 years with a history of smoking were recruited from a 
tertiary care center and evaluated using spirometry, plethysmography, FOT and pulmonary 
MRI in a single visit.  Ex-smokers with COPD were identified using the Global initiative 
for chronic Obstructive Lung Disease (GOLD) criteria.58  Disease control was evaluated in 
asthmatics using the Asthma Control Questionnaire (ACQ59 with permission) and in ex-
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smokers by monitoring exacerbation events requiring hospitalization.  The number of 
exacerbations requiring hospitalization was determined using patient hospital records 
during the 2.5 year period following the visit to the research center.  Patient quality of life 
was evaluated using the Asthma Quality of Life Questionnaire (AQLQ60 with permission) 
for asthma, and the St. George’s Respiratory Questionnaire (SGRQ61 with permission) for 
ex-smokers.  For participants with asthma, all imaging and pulmonary function tests (PFTs) 
were acquired at baseline and within 1.5 hours after administration of four 100µg doses of 
Novo-Salbutamol HFA (Teva Novopharm Ltd., Toronto, Canada) using a metered dose 
inhaler with an AeroChamber Plus spacer (Trudell Medical International; London, 
Canada).  In this work, only baseline measurements were investigated.  For ex-smokers, 
all data were acquired within 1.5 hours after administration of four 100µg doses of 
salbutamol as described for asthmatic patients.  Spirometry and body plethysmography 
were performed according to the American Thoracic Society (ATS) guidelines62 using a 
whole-body system (MedGraphics Corporation, Saint Paul USA).  FOT measurements 
were acquired using the TremoFlo C-100 Airwave Oscillometry System (Thorasys, 
Montreal CA). 
2.2.2 Image Acquisition and Analysis 
MRI was performed on a whole body 3T system (MR750 Discovery, GEHC, Milwaukee, 
WI) with broadband imaging capability.  3He MRI was acquired using a single-channel, 
rigid elliptical transmit/receive chest coil (RAPID Biomedical GmbH, Wuerzburg, 
Germany).  The 3He gas was polarized to 30-40% polarization using a spin-exchange 
optical polarizer (Polarean Inc, Durham, NC).  Subjects were positioned supine in the 
scanner with their arms raised above their head and inhaled a 1L gas mixture of 3He/N2 
(25% 3He by volume) from functional residual capacity (FRC).  Image acquisition was 
performed under breath-hold conditions.37  The hyperpolarized 3He MR images were 
analyzed using custom software as previously described.63  Briefly, a single user (HMY) 
placed seeds on the 1H and 3He MR images to label the lung and the surrounding tissue and 
image segmentation was completed using a convex optimization technique.  3He 
ventilation defects were identified using a k-means clustering approach,64 and ventilation 
defect percent (VDP) was calculated as the total ventilation defect volume normalized to 
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the thoracic cavity volume.  The ventilation cluster map for each subject was then non-
rigidly registered to the computational airway tree as previously described.52 
2.2.3 Computational Modeling 
We adapted a three-dimensional airway tree consisting of 64,895 airways (M. Tawhai, U. 
Auckland), to generate a computational airway tree model. A full description of the model 
was previously provided.47  To summarize, the airway tree was derived from a thoracic x-
ray computed tomography (CT) image including up to the eighth-generation airways and 
the remaining generations were constructed using a volume filling algorithm that preserved 
the anatomical branching geometry.47 
Airways located within two voxels (6.25mm) of an MRI ventilation defect or distal to a 
ventilation defect were labelled as related to the defect.  These airways were identified 
using custom software designed in MATLB and narrowed to 10% of their initial diameter, 
effectively increasing their resistance by a factor of 104 according to Poiseulle’s law.52  
Airways larger than the 14th generation in the airway tree were excluded to ensure that we 
evaluated only small airways < 2mm in diameter.  We evaluated the impact of small airway 
constriction, which has been shown to play a critical role in increased airway impedance 
and ventilation defects.49  Figure 2-1 shows a schematic outlining MR image processing 
steps, and the integration of MRI data into the computational model to generate patient-
specific predictions.  Airway impedance predictions were generated as previously 
described from these individually modified airway trees.51, 52  First, the airway lengths and 
diameters were reduced to 80% of their original TLC volume.  The flow in the non-terminal 
airways was described using Womersley flow65 using the following equation: 
	 𝑍1 𝑓 = 	 𝑖2𝑓𝜌1D)𝑙1𝑟1W 1 − 2𝐽Y 𝛼1 −𝑖𝛼1 −𝑖𝐽R 𝛼1 −𝑖 [Y	 (2.1)	
Where i is the unit imaginary number, f is the oscillation frequency in Hz, ρair is the density 
of air (1.16 kg/m3), la is the length and ra is the radius of the airway, J0 and J1 are the 
complex Bessel functions of order 0 and 1 respectively and αa is the Womersley number 
for the airway given by: 
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	 𝛼1 = 𝑟1 2𝜋𝜌1D)𝑓𝜇1D) 		 (2.2)	
Where µair is the dynamic viscosity of humid air at 37 degrees C (1.85 x 10-5 Pa.s). 
To model the compliance of the lung parenchyma, each terminal airway was modeled as 
an alveolar compartment with a known elastance.  Then, the impedance of a terminal 
airway is given by: 
	 𝑍C = 	𝑍1 − 𝑖 𝐸𝑡𝜔 	 (2.3)	
Where E is the elastance of the terminal airway unit, set to 53 cmH2O/L as was done 
previously.52  The resistance of the upper airways and the chest wall were each assigned a 
value of 0.5 cmH2O·s/L,66-68 and the elastance of the chest wall as assigned a value of 10.6 
cmH2O·s/L.69  Finally, the effects of upper airway shunt were included using previously 
published values.70  These values were added to the lung resistance and reactance to 
calculate the final values for Rrs and Xrs. 
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Figure 2-1: Pipeline for Co-Registration of MRI Ventilation Defects with 
Computational Airway Tree Model. 
(A) Hyperpolarized 3He MRI shown in cyan co-registered with anatomical 1H MRI in 
greyscale.  (B) The thoracic cavity, including the lungs, was automatically segmented using 
a manually-seeded algorithm and ventilation defects identified, shown in black.  (C) An 
asymmetric branching computational airway tree model used to calculated respiratory 
system impedance.  (D) The ventilation defect map was co-registered to the airway tree 
model.  The small airways that were within or distal to a ventilation defect were identified, 
and narrowed to 10% of their original diameter.  Ventilation defects are in grey and the 
airways related to defects are in yellow.   
2.2.4 Statistics 
The Shapiro-Wilk test was used to test data normality and non-parametric tests were used 
when the data were not normally distributed.  Independent samples t tests and Mann-
Whitney U tests were used to evaluate differences between asthma and COPD patients.  
Levene’s test for equality of variances was used to test if the variance in the data was equal 
between two groups and when the variance was not equal, Welch’s correction was applied 
to independent samples t tests.  The Holm-Bonferroni correction was used to adjust for 
multiple comparisons.  Univariate relationships were evaluated using Spearman 
correlations (ρ) because the data were not normally distributed.  Significant relationships 
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identified using Spearman correlation were evaluated using linear regression.  Results were 
considered statistically significant when the probability of making a Type I error was less 
than 5% (p < 0.05).  All statistical tests were performed using SPSS 24.0 (IBM).   
2.3 Results 
2.3.1 Participant Demographics 
As shown in Table 2-1, 100 participants were evaluated including 50 subjects with asthma 
(17 mild-moderate and 33 severe), and 50 ex-smokers.  Within the ex-smoker group, 28 
subjects had COPD (12 mild (GOLD I), 11 moderate (GOLD II) and 5 severe (GOLD III)).  
The ex-smokers were significantly older than the asthma subjects (p < 0.001).  FEV1 was 
significantly higher in the ex-smokers as compared to the asthmatic (p < 0.001) and the 
COPD subjects (p < 0.001), and plethysmography-measured airways resistance (Raw) was 
significantly greater  in the asthma group as compared to the COPD group (p < 0.001) and 
the ex-smokers (p < 0.001).   
Table 2-1: Participant Demographics 
Mean (±SD) All (n=100) 
Asthma 
(n=50) 
COPD 
(n=28) 
Ex-
Smokers 
(n=22) 
Asthma 
- COPD 
(p) 
Asthma - Ex-
Smokers (p) 
COPD - Ex-
Smokers (p) 
Male n 54 21 19 14 - - - 
Age years  61 (16) 49 (12) 75 (8) 70 (10) <0.001 <0.001 0.2 
BMI kg·m-2 28 (4) 28 (4) 26 (4) 30 (4) 0.5 0.03 0.003 
FEV1 %pred  78 (26) 70 (23) 74 (25) 102 (20) 1.0 <0.001 <0.001 
FVC %pred 89 (20) 83 (20) 94 (19) 95 (20) 0.06 0.1 1.0 
FEV1/FVC % 65 (15) 64 (15) 56 (10) 80 (15) 0.02 <0.001 <0.001 
TLC %pred 102 (15) 103 (15) 107 (16) 95 (13) 0.8 0.1 0.02 
RV/TLC % 43 (9) 41 (9) 47 (9) 40 (8) 0.04 1.0 0.04 
DLCO %pred - - 60 (21) 83 (15) - - <0.001 
Raw %pred  127 (80) 171 (83) 95 (43) 65 (25) <0.001 <0.001 0.6 
Sig Dif: significance of difference between groups determined with a one-way ANOVA with 
Bonferroni post-hoc test.  SD: standard deviation; %pred: percent of predicted value; BMI: body 
mass index; FEV1: forced expiratory volume in one second; FVC: forced vital capacity; TLC: total 
lung capacity; RV: residual volume; DLCO: diffusing capacity of the lung for carbon monoxide; 
Raw: airways resistance. 
 
As shown in Figure 2-2, subjects with COPD had significantly higher VDP than ex-
smokers (p < 0.001) and asthmatic subjects (p < 0.001), but there was not a significant 
difference in VDP between asthmatics and ex-smokers (p = 0.4).  FOT-measured reactance 
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(Xrs 5Hz) was significantly more negative in asthma as compared to COPD subjects (p = 
0.04) and ex-smokers (p = 0.02) and FOT-measured Rrs 5Hz and Rrs 5-19Hz, related to the 
obstruction of all airways and of the small airways respectively, were significantly greater 
in asthma as compared to COPD (Rrs 5Hz: p < 0.001, Rrs 5-19Hz: p < 0.001) and ex-
smokers (Rrs 5Hz: p < 0.001, Rrs 5-19Hz: p < 0.001).  There was no significant difference 
in FOT-measured Rre (Rrs 5Hz: p = 1.0, Rrs 5-19Hz: p = 0.8) or Xrs (p = 1.0) between ex-
smokers and COPD patients. 
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Figure 2-2: VDP and FOT-measured Resistance and Reactance in Asthma, COPD 
and Ex-Smoker Subgroups. 
(A) VDP for asthma and COPD (p < 0.001) and COPD and ex-smoker (p < 0.001) 
subgroups were significantly different, but VDP was not different between asthmatic and 
ex-smoker groups (p = 0.4). (B) FOT-measured Xrs 5Hz was significantly greater in the 
asthmatic as compared to the COPD subgroup (p = 0.04) and the ex-smoker group (p = 
0.02).  Xrs was not different between COPD and ex-smoker subgroups (p = 1.0). (C) FOT-
measured Rrs 5Hz was significantly greater in the asthmatic as compared to the COPD (p 
< 0.001) and ex-smoker (p < 0.001) subgroups, but it was not different between COPD and 
ex-smoker subgroups (p = 1.0). (D) FOT-measured Rrs 5-19Hz was significantly greater in 
the asthmatic as compared to the COPD (p < 0.001) and ex-smoker (p < 0.001) subgroups, 
but was not different between COPD and ex-smokers (p = 0.8).   
* The two non-COPD ex-smokers who experienced exacerbations are indicated by the 
symbol ( ) ES4: FEV1=102%pred, FVC= 97%pred, FEV1/FVC=80%, Rrs 5Hz=4.0 
cmH2O·s/L, Xrs5Hz=-1.7cmH2O·s/L, Rrx5-19Hz=0.0cmH2O·s/L, VDP=2%.  ES14: 
FEV1=81%pred, FVC=70%pred, FEV1/FVC=88%, Rrs 5Hz=4.0cmH2O·s/L, Xrs 5Hz=-
2.4cmH2O·s/L, Rrx 5-19Hz= 0.3cmH2O·s/L, VDP=1%. 
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2.3.2 FOT and 3He MRI VDP Relationships 
As shown in Figure 2-3, MRI VDP was significantly correlated with FOT-measured 
respiratory system resistance (Rrs 5Hz: ρ = 0.3, p = 0.02) and reactance (Xrs 5Hz: ρ = -0.5, 
p < .001) in asthmatics, while these measurements were not correlated in COPD patients 
(Rrs 5Hz: ρ = -0.04, p = 0.8; Xrs 5Hz: ρ = -0.2, p = 0.4) or ex-smokers (Rrs 5Hz: ρ = -0.3, p 
= 0.2; Xrs 5Hz: ρ = 0.3, p = 0.2).  In both asthmatics (ρ = 0.5, p < 0.001) and COPD patients 
(ρ = 0.5, p = 0.01), small airways resistance (Rrs 5-19Hz) was significantly correlated with 
VDP, but these measurements were not correlated in ex-smokers (ρ = -0.2, p = 0.4).  
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Figure 2-3: Relationships for VDP and FOT measurements 
Top: FOT-measured Rrs 5Hz was significantly correlated with VDP in asthmatics (slope 
= 0.05±0.03, ρ = 0.3, p = 0.02) but not in COPD patients (ρ = -0.04, p = 0.8) or ex-smokers 
(ρ = -0.3, p = 0.2).  FOT-measured Xrs 5Hz was significantly correlated with VDP in 
asthmatics (slope = -0.12±0.04, ρ = -0.5, p < 0.001) but not in COPD patients (ρ= -0.2, p= 
0.4) or ex-smokers (ρ = 0.3, p = 0.2).  FOT-measured Rrs 5-19Hz was significantly 
correlated with VDP in both asthmatic (slope = 0.07±0.02, ρ = 0.5, p < 0.001) and COPD 
patients (slope = 0.02±0.007, ρ = 0.5, p = 0.01) but not in ex-smokers (ρ = -0.2, p = 0.4).  
Centre: Three representative asthmatic subjects with worsening VDP and FOT-measured 
impedance from left to right.  Bottom: Three representative COPD subjects with worsening 
VDP and FOT-measured impedance from left to right. 
 
 48 
 
2.3.3 Relationships with Disease Control and Quality of Life Scores 
All participants with asthma were stratified using the ACQ (well controlled = ACQ ≤ 2, 
poorly controlled = ACQ > 2) as previously described.12  Ex-smokers (including subjects 
with and without COPD) were classified based on the presence of an exacerbation requiring 
hospitalization within 2.5 years, such that patients who had been hospitalized at least once 
due to COPD or pneumonia were classified as poorly controlled. Nine out of fifty ex-
smokers were poorly controlled, including 7 COPD patients and 2 subjects from the non-
COPD group.  As shown in Figure 2-4, FEV1 was significantly different in poorly-
controlled asthmatic patients (p = 0.04) but not ex-smokers (p = 0.08).  Plethysmography-
measured Raw was significantly greater in poorly- controlled asthma (p = 0.03) and ex-
smokers (p = 0.04), while VDP was significantly greater in patients with poorly-controlled 
asthma (p = 0.03) but not in ex-smokers with exacerbations (p= 0.1).  In poorly-controlled 
asthmatics, FOT-measured respiratory system reactance (Xrs 5Hz, p=0.03) and resistance 
of all airways (Rrs 5Hz, p = 0.01) and the small airways resistance (Rrs 5-19Hz, p = 0.006) 
were significantly different than in well-controlled asthmatics.  None of the FOT measures 
of airway impedance (Xrs 5Hz, p=0.2; Rrs 5Hz, p=0.6; Rrs 5-19Hz, p=0.3) were 
significantly different in ex-smokers with exacerbations. 
 49 
 
 
Figure 2-4: Differences in FEV1, VDP and FOT Impedance Stratified by Disease 
Control. 
Subjects were stratified based on disease control using the asthma control questionnaire 
(ACQ) for asthmatics or the presence of at least a single exacerbation requiring 
hospitalization in ex-smokers (including those with and without COPD).  (A) FEV1 was 
significantly different in asthma patients with poor control (p = 0.04) but not in ex-smokers 
(p = 0.08).  (B) Plethysmography-measured Raw was significantly decreased in poorly-
controlled asthmatic patients (p = 0.03) and ex-smokers (p = 0.04).  (C) VDP was 
significantly increased in poorly-controlled asthmatics (p =0.03) but not in ex-smokers 
experiencing an exacerbation (p = 0.1).  (D) FOT-measured Xrs 5Hz was significantly 
different in poorly-controlled asthmatics (p= 0.03) but not in ex-smokers experiencing an 
exacerbation (p = 0.2).  (E) FOT-measured Rrs 5Hz was significantly increased in poorly-
controlled asthmatics (p = 0.01) but not in ex-smokers (p = 0.6).  (F) FOT-measured Rrs 5-
19Hz was significantly different in poorly-controlled asthmatics (p = 0.006) but not in ex-
smokers (p = 0.3).  * The two non-COPD ex-smokers who experienced exacerbations are 
indicated by the symbol ( )  
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In asthmatics, as shown in Figure 2-5, AQLQ score was correlated only with FOT-
measured small airways resistance (Rrs 5-19Hz; ρ = -0.3, p = 0.04) and VDP (ρ = -0.3, p = 
0.04) and not with any other measurement acquired.  Quality of life in COPD patients 
measured using the SGRQ score was significantly correlated with FEV1 (ρ = -0.5, p = 
0.006), Raw (ρ = 0.4, p = 0.03), FOT-measured resistance of the small airways Rrs 5-19Hz 
(ρ = 0.4, p = 0.04) and VDP (ρ = 0.6, p = 0.003).  SGRQ scores were not significantly 
related to FOT-measured resistance Rrs 5Hz (ρ = 0.1, p = 0.5) or reactance, Xrs 5Hz (ρ =- 
0.2, p = 0.3).  In the non-COPD ex-smoker group, SGRQ scores were only significantly 
related to plethysmography-measured Raw (ρ = 0.5, p = 0.01).   
 51 
 
 
Figure 2-5: Relationships between FOT-measured Resistance and MRI VDP with 
Quality of Life.  
Quality of life was measured using the Asthma Quality of Life Questionnaire (AQLQ) and 
the St. George’s Respiratory Questionnaire (SGRQ).  In asthmatics, AQLQ relationships 
with (A) FOT-measured Rrs 5Hz (ρ = -0.2, p =0 .2), (B) FOT-measured Rrs 5-19Hz (slope 
= -0.4±0.2, ρ = -0.3, p = 0.04), and (C) MRI-measured VDP (slope = -2.2±0.9, ρ = -0.3, p 
= 0.04).  In COPD patients and ex-smokers, SGRQ relationships with (D) FOT-measured 
Rrs 5Hz (COPD: ρ = 0.1, p =0.5; ES: ρ = 0.4, p =0.07), (E) FOT-measured Rrs 5-19Hz 
(COPD: slope = 0.01±0.006, ρ = 0.4, p = 0.04; ES: ρ = 0.2, p =0.3), and (F) MRI-measured 
VDP (COPD: slope = 0.3±0.1, ρ = 0.6, p = 0.003; ES: ρ = -0.3, p =0.2).   
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2.3.4 Experimental and Model Impedance Measurements 
As shown in Figure 2-6, FOT-measured resistance of all airways (Rrs 5Hzmeas) was not 
significantly related to model-predicted resistance (Rrs 5Hzpred) in asthmatics (ρ = 0.2, p = 
0.2) nor in ex-smokers (ρ = -0.3, p = 0.2) and COPD patients (ρ = 0.001, p = 1.0). However, 
FOT-measured respiratory system reactance (Xrs 5Hzmeas) was significantly related to 
model-predicted reactance (Xrs 5Hzpred) in asthmatics (slope = 1.4±0.6, ρ = 0.5, p = 0.001) 
but not in COPD patients (ρ = 0.2, p = 0.4) or ex-smokers (ρ = -0.3, p = 0.2).  In contrast, 
FOT-measured small airway resistance (Rrs 5-19Hzmeas) was significantly correlated with 
model-predictions (Rrs 5-19Hzpred) in COPD patients (slope = 2.6±0.7, ρ = 0.5, p = 0.004) 
but not in ex-smokers (ρ = -0.1, p = 0.6) or asthmatics (ρ = 0.2, p = 0.1).   
 
Figure 2-6. Relationships for Model-predicted and FOT-measured Respiratory 
System Impedance.  
(A) FOT-measured Rrs 5Hzmeas was not significantly related to model-predicted Rrs 5Hzpred 
in asthma (ρ = 0.2, p = 0.2), COPD patients (ρ = 0.001, p = 1.0) or ex-smokers (ρ = -0.3, p 
= 0.2).  (B) FOT-measured Xrs 5Hzmeas was significantly related to model-predicted Xrs 
5Hzpred in asthmatic patients (slope = 1.4±0.6, ρ = 0.5, p = 0.001) but not in COPD patients 
(ρ = 0.2, p = 0.4) or ex-smokers (ρ = -0.3, p = 0.2).  (C) FOT-measured Rrs 5-19Hzmeas was 
significantly correlated with model-predicted Rrs 5-19Hzpred in COPD (slope = 2.6±0.7, ρ 
= 0.5, p = 0.004) but not in asthmatics (ρ = 0.2, p = 0.1) or ex-smokers (ρ = -0.1, p = 0.6).    
 
2.4 Discussion 
In ex-smokers and patients with asthma, 3He MRI ventilation heterogeneity and 
oscillometry measurements were evaluated as was their relationship with one another, with 
quality of life scores and with disease control/exacerbations. We also generated respiratory 
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impedance predictions using an airway tree model modified based on patient-specific MRI 
ventilation maps and evaluated model-based and experimental impedance measurements.  
We made a number of important observations including: 1) in asthmatics, MRI VDP was 
related to FOT-measured Xrs 5Hz, Rrs 5Hz  and Rrs 5-19Hz, but in COPD patients, only 
VDP and Rrs 5-19Hz were related and in ex-smokers MRI VDP was not related to FOT-
measured impedance, 2) VDP and FOT-measured Xrs and Rrs were independently 
correlated with AQLQ (in asthmatics) and SGRQ (in COPD patients) but were not 
correlated with SGRQ in ex-smokers without COPD, 3) FOT-measured impedance and 
MRI VDP were independently related to disease control in asthmatic patients but not in 
ex-smokers or COPD patients, and finally, 4) in patients with asthma, measured and 
predicted respiratory impedance (Xrs 5Hz) were significantly correlated, whereas in 
patients with COPD, only measured and predicted small airways resistance (Rrs 5-19Hz) 
were related.   
2.4.1 FOT and 3He MRI Ventilation Heterogeneity 
First, we observed that FOT-measured Rrs and Xrs were correlated with MRI VDP, 
providing direct evidence that the biomechanical properties of the respiratory system are 
related to ventilation heterogeneity in both asthma and COPD patients.  In particular, in 
asthmatics, Rrs, Xrs and Rrs 5-19Hz were all related to VDP, but in COPD, only Rrs 5-19Hz 
was related.  This suggests that there are differences in the etiology of ventilation defects 
in asthmatic and COPD patients, and that in the COPD patients studied here, VDP was 
dominated by small airway resistance.  Interestingly, non-COPD ex-smokers had similar 
small airway resistance to the subjects with COPD, but had significantly lower VDP.  This 
suggests that similar biomechanical changes are present in ex-smokers, but they are not 
severe enough to cause ventilation defects.  These findings certainly support the ongoing 
conversation about the important role of small airways disease in COPD patients71 and 
provide new impetus for the development of small airway treatments of COPD.  Previously 
described computational modelling49 and ventilation heterogeneity studies72 have focused 
on asthma but to our knowledge, our observations in COPD patients are novel.  A recent 
SPECT study14 evaluated the impact of bronchoconstriction in asthmatics and suggested 
that respiratory impedance may be too complex to be directly evaluated using ventilation 
 54 
 
imaging.  However, here we showed that MRI ventilation abnormalities may be explained 
by oscillometry measurements and surprisingly, MRI ventilation abnormalities measured 
during a static breath-hold may be explained by impedance measurements made during 
tidal breathing. 
2.4.2 FOT, Disease Control and Quality of Life 
Second, we observed that FOT-measured small airways resistance and VDP were related 
to quality of life scores in patients with asthma and COPD, but not in ex-smokers.  This is 
important because for FEV1, which is the most commonly used measurement of obstructive 
lung disease, relationships with important outcomes like quality of life are generally weak 
to insignificant.73-75  As patient-centered care becomes a priority in clinical settings, the 
ability to relate physiological measurements to patient quality of life is increasingly 
important.  This has motivated the development of tools that are more sensitive to these 
important patient outcomes so that they may be predicted in individual patients.  Our results 
suggest that FOT and MRI provide clinically-useful measurements, for this purpose, in 
asthmatics and COPD patients. 
Perhaps more importantly for clinical decision makers, while we observed that 
plethysmography-measured Raw was significantly worse in asthmatics, ex-smokers and 
COPD patients with poorly controlled disease, FOT-measured Rrs and Xrs as well as VDP 
were all significantly worse in poorly-controlled asthmatics. While we did not observe 
significant relationships in COPD patients or ex-smokers, some of these relationships were 
certainly trending towards significance and this result may stem from the small number of 
exacerbations in these patients – which was used as a surrogate endpoint for disease 
control.  It is understood that Raw and Rrs are significantly correlated, although these 
correlations are not always strong.76  A power analysis assuming unequal sample size using 
hospitalizations as a conservative measure of disease control revealed that 104 ex-smokers 
(including COPD patients) would be required for Rrs 5-19Hz as a predictor of 
hospitalizations, while only 40 patients would be needed for Raw.  Larger studies to 
investigate the power of both FOT and MRI to predict and prevent COPD hospitalization 
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will be important because COPD exacerbations comprises a very large health utilization 
burden in Canada77, 78 and around the world.79, 80   
2.4.3 Measured Impedance and Image Functional Modeling 
Finally, we generated impedance predictions using an airway tree model adapted using 
ventilation MRI measurements.  We were not surprised to find that the experimental and 
model-predicted values of Rrs 5Hz were not significantly correlated, because it is likely 
that some airway narrowing may not directly lead to ventilation defects in patients.  We 
also observed that FOT-measured and model-predicted reactance (Xrs) were significantly 
related in asthmatics, which was in agreement with previous findings.32, 51, 81  Finally, the 
measured and predicted resistance reflecting the small airways (Rrs 5-19Hz) were 
significantly correlated in COPD patients, but not asthmatics and this is consistent with our 
understanding of the dominant role of small airways disease in COPD.71  It is important to 
note that while there were moderately strong correlations between the measured and 
predicted impedance values, the predicted values were significantly smaller (based on the 
slopes of the linear regression).  This was expected because previous work51 showed that 
up to 75% of the small airways need to be constricted to achieve model and experimental 
measurement agreement.  Impedance predictions were systematically underestimated51 
when only airways within a defect were considered, supporting previous demonstrations48 
that showed constriction of airways beyond those proximal to ventilation defects is 
required to simulate impedance measurements in asthmatics.   
2.4.4 Limitations 
We acknowledge and recognize a number of study limitations, including the fact that we 
considered ventilation defects only and not regions of decreased or partial ventilation.  
Based on previous modeling studies48 and MRI evidence of patchy ventilation sometimes 
observed in asthmatics and ex-smokers, it would be relevant to consider hyper-intense 
ventilation regions as well as hypo-intense regions that are not captured by VDP. We note 
as well that the airway tree47  used in the modelling studies was not patient-specific, nor 
were the impedance values of the upper airway and chest wall.  However, we expect these 
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factors to contribute much less to Rrs and Xrs than the changes occurring within the lung 
itself in obstructive lung disease.  Despite these limitations, we observed significant 
correlations between measured and model-predicted impedance for the small airways 
which is important for further model development.  Another limitation of this work is the 
use of hospitalizations as a surrogate measure of disease control in ex-smokers.  While 
hospitalizations have the highest impact on patients and the health-care system,77 only nine 
of fifty ex-smokers studied here experienced an exacerbation which certainly diminished 
statistical power.  A retrospective power analysis showed that 104 ex-smokers would be 
required to determine the role of FOT impedance measurements as predictors of COPD 
hospitalizations; larger studies will be needed to explore these relationships.  Finally, while 
we observed significant relationships between FOT measurements of resistance and 
reactance with MRI VDP and patient quality of life, these relationships were of moderate 
to weak strength.  This means that there are other variables that have not yet been fully 
accounted for, and further work must be done to fully understand how respiratory 
impedance and ventilation heterogeneity are related to patient outcomes.   
2.4.5 Conclusions 
In conclusion, we made oscillometry and MRI measurements in ex-smokers and patients 
with asthma and directly compared these measurements with disease control and patient 
quality of life scores.  We observed significant relationships for FOT-measured impedance 
and VDP with quality of life, providing strong evidence that airway resistance and 
reactance are reflective of MRI ventilation defects, and importantly they both explain 
quality of life in patients.  We also used MRI ventilation defects to generate patient-specific 
computational airway model predictions of respiratory system impedance and, for the first 
time, compared these predictions with experimental measurements.  Taken together, these 
results provide strong motivation for multiscale studies that explore how small airways 
disease and ventilation abnormalities may explain and help improve disease control and 
quality of life in patients.    
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CHAPTER 3 
3 CONCLUSIONS AND FUTURE DIRECTIONS 
3.1 Overview and Research Questions 
Obstructive lung disease represents a huge health care burden in Ontario1 and worldwide,2 
reflecting the need for a better understanding of the mechanisms of disease and how they 
can be treated.  While obstructive lung disease is known to be spatially heterogeneous and 
to involve small airway dysfunction, the structure-function relationships related to 
ventilation defects are not fully understood.  The objective of this thesis was to apply the 
forced oscillation technique (FOT), hyperpolarized 3He magnetic resonance imaging 
(MRI), and computational airway tree modelling to study obstructive lung disease.  The 
specific research questions were: 1) How are structural and mechanical changes measured 
by FOT related to MRI ventilation defects?  2) How do these measures of ventilation 
heterogeneity relate to disease control and patient quality of life in obstructive lung 
disease?   
3.2 Summary and Conclusions 
In this thesis, I evaluated 100 subjects (50 asthma, 28 COPD, 22 ex-smokers) using quality 
of life questionnaires, FOT, and hyperpolarized 3He MRI.  I sought to measure the 
relationships between respiratory system impedance, MRI ventilation heterogeneity, and 
patient quality of life.  I also developed upon previous work using MRI ventilation defects 
to modify a computational airway tree model to generate patient-specific predictions of 
airway impedance and compared them to FOT-measured impedance in all 100 patients.3  
FOT-measured small airways resistance was significantly correlated with VDP in both 
asthma (ρ=0.5, p<0.001) and COPD (ρ=0.5, p=0.01) but not in ex-smokers (ρ=-0.2, p=0.4), 
and only in asthma was respiratory system impedance (Xrs 5Hz: ρ=-0.5, p<0.001; Rrs 5Hz: 
ρ=0.3, p=0.02; Rrs 5-19Hz: ρ=0.5, p<0.001) related to VDP.  FOT-measured small airways 
resistance (COPD: ρ=0.4, p=0.04; asthma: ρ=-0.3, p=0.04) and MRI-measured VDP 
(COPD: ρ=0.6, p=0.003; asthma: ρ=-0.3, p=0.04) were the only metrics that were 
significantly related to patient quality of life in these two groups.  In ex-smokers without 
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COPD, only plethysmography-measured Raw was significantly related to quality of life 
(ρ=0.5, p=0.01).  Asthmatic patients with poor asthma control had significantly increased 
respiratory system impedance (Rrs 5Hz, p=0.01; Xrs 5Hz, p=0.03), and increased small 
airways resistance (Rrs 5-19Hz p=0.006).  Predicted reactance (Xrs 5Hz) was correlated 
with FOT-measured reactance in asthma (ρ=0.5, p=0.001), and predicted resistance 
reflecting small airways dysfunction (Rrs 5-19Hz) was correlated with measured values in 
COPD (ρ=0.5, p=0.004).  Predicted and FOT-measured resistance and reactance were not 
correlated in ex-smokers without COPD (Rrs 5Hz ρ=-0.3, p=0.2; Xrs 5Hz ρ-0.3, p=0.2; Rrs 
5-19Hz ρ=-0.1, p=0.6).  This study provided strong evidence that heterogeneous small 
airway obstruction is related to ventilation defects, and importantly, both are related to 
quality of life in obstructive lung disease.   
3.3 Limitations 
In this section the most significant limitations from Chapter 2 will be discussed.  It should 
be noted that these limitations are also presented in the Discussion section of Chapter 2.  
In Chapter 2 I evaluated 100 patients with obstructive lung disease with severity ranging 
from mild to severe using hyperpolarized 3He MRI and FOT to study the relationships 
between structure and function in obstructive lung disease.  However, I did not evaluate 
any COPD patients with GOLD stage IV (very severe) disease and only 5 patients with 
GOLD stage III (severe) disease.  This study could therefore be improved by the inclusion 
of more patients in these severe and very severe categories, in order to study the changes 
in structure and function together as disease worsens.   
It should be noted that while there were moderately strong correlations between the FOT-
measured and model-predicted impedance values, the predicted values were consistently 
less than those measured by FOT.  This is consistent with previous work4 using the same 
computational model (scaled so that the predicted impedance with no constriction 
corresponded with measured impedance in healthy volunteers).  The authors showed that 
up to 75% of the small airways had to be constricted in asthma in order for the predicted 
impedance values to correspond with FOT measurements, suggesting that when only 
airways within a defect are considered, impedance is systematically underestimated in this 
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model.  This supports another previous study5 suggesting that constriction of airways 
outside ventilation defects is necessary to generate accurate impedance predictions in 
asthma.  Therefore, a limitation of the present work is that I implemented a binary approach 
where airways either remained at 100% of their original diameter, or were reduced to 10% 
of their original diameter.  In reality, there is likely a distribution of narrowed airways 
throughout the lung, with the most severe narrowing occurring in ventilation defects.  
Future work will expand on this model by using MRI ventilation data to incorporate 
moderate airway narrowing outside ventilation defects as explained in Section 3.4.3.   
The airway tree modelling calculations are also subject to several limitations.  First, while 
the model was modified to reflect the unique distribution of ventilation defects for each 
patient, this model did not exactly represent each patient’s airway tree geometry.  Rather, 
it was generated from a representative healthy female subject6 and modified to reflect some 
of the functional changes measured in these subjects.  I also used representative values for 
the impedance of the upper airway and chest wall for all impedance predictions, so the 
variation of these parameters between patients was not accounted for.  However, these 
factors are expected to contribute much less to Rrs and Xrs than the changes occurring within 
the lung in obstructive lung disease.  Despite these limitations, I demonstrated significant 
correlations between FOT-measured and model-predicted impedance from small airway 
obstruction in ventilation defects alone.  This emphasizes the importance of small airway 
dysfunction in ventilation defects and in respiratory system impedance. 
3.4 Future Directions 
3.4.1 FOT Biomarkers in Severe Asthmatics Undergoing Bronchial 
Thermoplasty 
While small airway dysfunction is hypothesized to play an important role in asthmatic 
ventilation heterogeneity, constriction of larger airways is also known to occur, especially 
in severe asthma.  Bronchial thermoplasty (BT) is an invasive treatment that targets the 
smooth muscle in these larger airways to prevent constriction, with the goal of improving 
symptoms and disease control.7  This treatment has shown promise for improving 
pulmonary function in early studies,8, 9 but there is debate over how widely applicable this 
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may be as it does not treat the small airways directly.  FOT is sensitive to obstruction in 
the central and peripheral airways independently, and can be easily integrated into clinical 
workflows.   
As part of a study that is currently underway, we have collected FOT impedance 
measurements and ventilation MRI in several severe asthmatics who are candidates for BT 
before and after treatment.  By comparing the FOT, MRI, and other functional data before 
and after BT, we may be able to better understand how ablation of smooth muscle in the 
large and mid-sized airways affects breathing mechanics and airflow through the rest of 
the lung.  This will provide a more complete understanding of the effects of BT on the lung 
beyond the specific ablated airways, and how these changes affect lung function and patient 
quality of life. 
3.4.2 FOT Biomarkers and Higher-Order Image Features in 3He MRI 
In this thesis, 3He MRI was used to quantify ventilation heterogeneity by calculating the 
VDP.  This was done by sorting the signal intensities into one of five clusters, and mapping 
the lowest-intensity cluster within the lung.10  However, there is a wealth of other 
ventilation information available in 3He MR images beyond this validated biomarker.  By 
investigating other intensity-based metrics and other spatial features available in each 
image, we may be able to account for other aspects of ventilation heterogeneity that may 
be reflected by oscillometry.   
For example, higher-order metrics have previously been proposed to evaluate 
heterogeneity in obstructive lung disease.11  While the clinical meaning of these metrics 
may not yet be fully understood, the combination of MRI heterogeneity analysis and FOT 
measurements of impedance may yield new insights into the clinical relevance of these 
higher-order ventilation measurements. 
In addition, pulmonary imaging may be able to differentiate between heterogeneous 
ventilation patterns related to the obstruction of small airways alone and obstruction with 
large airway involvement. This may be possible using functional information derived from 
MRI, and structural information derived from CT.  Using high-resolution CT imaging, 
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airway trees can be resolved and segmented until the airways are approximately 2mm in 
diameter (the typical threshold for identifying the ‘small airways’).  Using deformable co-
registration techniques, ventilation maps may be co-registered to the patient’s airway tree 
and ventilation abnormalities may be classified as related to a large airway, or only in the 
small airways.  This classification can then be compared to FOT measurements related to 
central and peripheral airway narrowing for validation.  The ability to identify which 
defects are related to large or small airway dysfunction is important in the development of 
novel treatments for asthma. 
3.4.3 Image Functional Modeling Incorporating all MRI Ventilation  
One of the limitations of this thesis, as discussed in Section 3.3, is the fact that when the 
computational airway tree was modified using patient ventilation MRI data, only airways 
that were within or distal to a ventilation defect were narrowed.  Using this method, airways 
within regions of the lung that are otherwise abnormally ventilated are not taken into 
account.  This may have been part of the reason that, while there was moderately strong 
correlation between measured and predicted impedance, predicted impedance was 
consistently lower than impedance measured by MRI.  However, it has been suggested in 
other modeling studies that in order to replicate experimental FOT measurements of 
impedance, moderate narrowing of many or all airways in the tree is necessary.4, 5  In my 
MRI analysis 3He MRI ventilation data was grouped into five clusters using a k-means 
approach, meaning that other levels of increased or decreased ventilation have been 
quantified, but not yet incorporated into the model.  By scaling the diameter of each airway 
in a manner that corresponds to the ventilation measured in that region, we may be able to 
produce more accurate patient-specific predictions of impedance.  
3.5 Significance and Impact 
Obstructive lung disease affects hundreds of millions of people globally, and is responsible 
for millions of deaths each year.2  Despite the prevalence and impact of this disease and 
decades of ongoing research, we are still developing our understanding of how obstructive 
lung disease affects structure and function, and how these changes are related to quality of 
life and exacerbations for these patients.  Many patients do not have well-controlled disease 
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with currently available therapies.  Hyperpolarized 3He MRI has advanced our 
understanding of the spatially heterogeneous nature of these diseases, but the structural 
changes related to the ventilation heterogeneity we observe are still not fully understood.  
In order to advance our understanding of structure-function relationships in asthma and 
COPD, there is a need for multi-modality studies that incorporate more structural and 
functional measurements.   
In this thesis I evaluated 100 patients with obstructive lung disease using hyperpolarized 
3He MRI, FOT, and quality of life questionnaires. I showed significant relationships 
between FOT-measured impedance and quality of life, as well as with MRI VDP.  This 
study provided strong evidence that heterogeneous small airway obstruction is implicated 
in ventilation defects observed with MRI, and importantly, is related to quality of life in 
obstructive lung disease.  I also used MRI ventilation defects to generate patient-specific 
computational model predictions of airway impedance and, for the first time, showed that 
predictions of reactance in asthma and resistance in COPD were significantly related to 
FOT-measured impedance.  These results provide strong support for the broader clinical 
implementation of FOT for evaluating obstructive pulmonary disease.  FOT is a clinically 
applicable method that I have shown to be significantly related to patient quality of life and 
to asthma control.  Wider use of this technology may help to improve disease control, 
reducing the burden of obstructive lung disease on patients and on the Canadian health care 
system. 
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Appendix B – Asthma Quality of Life Questionnaire 
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Appendix C – St. George’s Respiratory Questionnaire 
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Appendix D – MRI and CT Lung Biomarkers: Towards an In Vivo Understanding 
of Lung Biomechanics 
This review paper presents the historical and current use of MRI and CT for in vivo studies 
of lung biomechanics. 
 
The contents of this chapter were previously published in Clinical Biomechanics: HM 
Young, RL Eddy and G Parraga. MRI and CT lung biomarkers: Towards an in vivo 
understanding of lung biomechanics. Invited Review, Clinical Biomechanics. In Press. doi: 
10.1016/j.clinbiomech.2017.09.016. Permission to reproduce this article was granted by 
Elsevier and is provided in Appendix E. 
1.  Introduction 
The respiratory system, dominated by the working of the lungs, is necessarily elastic, 
undergoing complex biomechanical changes to enable breathing for efficient gas exchange.  
The lungs are over-engineered for day-to-day tasks, making detection and deep 
understanding of lung diseases and their biomechanical mechanisms extremely 
challenging.  The lungs are composed of different tissues and compartments including the 
large and small airways, blood vessels and parenchymal tissue.  The biomechanical 
properties of the respiratory system are therefore interdependent and derive from these 
complex structures.   
 
As shown in Figure 1, the overarching function of the respiratory system and the lungs is 
to deliver oxygen to the bloodstream and to remove CO2; this functionality can be 
measured in part by evaluating ventilation.  Total lung ventilation is the rate of air 
expiration from the lungs (mL/min), while alveolar ventilation is the rate at which fresh air 
enters the respiratory zone and is made available for gas exchange.1 This is achieved 
through the biomechanical process of breathing whereby muscle contraction and relaxation 
and thoracic cavity pressure changes allow air to flow in and out of the lungs.1  The 
relationship between volume, pressure and flow can be described using the mechanical 
properties of the lung tissue, which include the parenchyma, airways and airspaces.  Many 
diseases of the lung are a result of inflammation, fibrosis, airway constriction and 
parenchymal destruction.  These processes change its mechanical properties and 
understanding the biomechanical properties of the lung is essential when evaluating its 
function in order to understand the disease.2   
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Figure 4-1. Respiratory System Mechanics and Function 
1. Through the contraction of the diaphragm (A) and the intercostal muscles (B), the 
thoracic cavity expands via the outward motion of the ribcage and the downward motion 
of the diaphragm, decreasing the air pressure within the thoracic cavity.  2. Fresh air flows 
into the lungs through the airways and reaches the alveoli, where oxygen diffuses into the 
bloodstream.  3. The diaphragm (D) and the intercostal muscles (E) relax causing the 
ribcage to move inward, increasing the pressure in the thoracic cavity.  4. Carbon dioxide 
has diffused from the bloodstream into the alveoli, and is removed as air flows back out of 
the lungs through the airways. 
 
1.1 Clinical Measurements of Lung Biomechanics: Strengths and Limitations 
In clinical evaluations, the biomechanics of the lung are quantified through measurements 
of volume, flow and pressure of air, usually taken at the mouth.  These measurements are 
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simple and inexpensive to acquire, and are therefore widely used.  The primary clinical 
biomarker of lung function is the spirometry measurement of forced expiratory volume in 
one second (FEV1). This measurement is highly variable,3 and in asthma and chronic 
obstructive lung disease, FEV1 correlates weakly with quality of life and other patient 
outcomes.4  It also provides little information about the biomechanical cause of airflow 
limitation, in part because FEV1 provides a global lung measure and cannot capture 
regional information.  Other tools for measuring lung biomechanics include multiple-
breath inert gas wash-in and wash-out5 for the lung clearance index (LCI),5 measuring 
ventilation heterogeneity,6, 7 and the forced oscillation technique (FOT).8  FOT measures 
resistance and elastance of the central and peripheral airways independently and has been 
validated using direct measures of impedance.9  While these tools provide important 
information related to lung biomechanics and are well understood, they cannot distinguish 
the regional contributions of different lung components.  For this information, novel lung 
imaging tools are required.    
 
1.2  Solutions Provided by Pulmonary Imaging 
Pulmonary imaging provides a way to visualize and quantify lung structure and function 
with high spatial and temporal resolution in order to better understand in vivo regional lung 
biomechanics.  Pulmonary disease is heterogeneously distributed throughout the lung and 
pulmonary imaging is uniquely able to quantify the severity and distribution of disease in 
a way that directly reflects lung function and pathophysiology.  As summarized in Table 
1, a number of pulmonary imaging techniques can be used to measure numerous 
biomechanical properties of the lung.  These imaging tools can be classified into three main 
categories: microstructural, anatomical and functional imaging.  In this review, we 
summarize and discuss imaging methods required to generate imaging biomarkers of lung 
biomechanics, and how these measurements may be used to provide a greater 
understanding of pulmonary function.  As summarized in the schematic in Figure 2, a wide 
variety of lung biomechanical measurements can be derived using both x-ray based and 
magnetic resonance imaging (MRI) methods.   
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Table 4-1. Pulmonary Imaging-Derived Biomechanical Measurements 
Method	 Imaging	Biomarker*	 Biomechanical	Property	
Microstructural		 Alveolar	diameter10-12	 Acinar	deformation	
Imaging	 Surface-to-volume	ratio13-15	 Microstructural	elasticity	
	 	 	
Anatomical		 Volume	change	 Tissue	expansion	
Imaging	 Jacobian	determinant16-21	 Tissue	deformation,	compliance	
	 4DCT	Jacobian	determinant22-24	 Deformation	hysteresis		
	 Deformation	anisotropy24,	25	 Forces	and	strain	in	tissue	
	 Lobar	deformation26	 Lobar	mechanics	
	 	 	
Functional		 Wash-in	and	washout	time	constants27,	28	 Airflow	distribution	
Imaging	 Ventilation29-33	 Ventilation	heterogeneity	
	 Specific	ventilation34-36	 Tissue	expansion	
	 Apparent	diffusion	coefficient,	airspace	
morphometry37	
Transpulmonary	pressure,	
elasticity	
*Citations are included in Reference section 
 
 
 
Figure 4-2. Pulmonary Imaging Biomarkers of Lung Biomechanics 
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1.2.1 Micro-CT and Synchrotron x-ray Microscopy 
The functional units of the lung, including the terminal airways and the alveoli, are too 
small (ranging from 100-600 µm in diameter)1 and too deeply positioned in the body to be 
resolved using clinical imaging methods.  However, they play a vital mechanical role, so 
it is very important to be able to measure and understand these structures.  Our 
understanding of the geometry and features of the acinar ducts was generated from lung 
tissue samples and ex vivo histology measurements, pioneered by pulmonary pathologists 
and stereologists over the past decades.38-40  These measurements and approaches have 
provided a deeper understanding of normal tissue39 and tissues from asthmatics and COPD 
patients,41 but such methods are dependent on lung tissue excision and ex vivo analyses.  
The potential for in vivo measurements in animal models and patients was first 
demonstrated using micro-computed tomography (micro-CT), and exploited by Hogg and 
collaborators.42, 43  The concept of micro-CT was reduced to practice and commercialized 
between 1994-200144 and was initially used for geological core sample evaluations45, 46 and 
small animal bone studies.47, 48  Micro-CT generates high-resolution 3D images of small 
samples, providing direct, non-invasive measurements of lung anatomy and 
microstructure.  This technique has been used to study the destruction and remodeling that 
occurs in the small airways in COPD,43 and confirmed the narrowing and loss of small 
conducting airways in COPD as compared to healthy controls.49  Current micro-CT 
methods have been used for hypothesis driven pulmonary research in ex vivo50 and in vivo14 
small animal studies and to image excised samples of human lung tissue.42  In these studies, 
the first in vivo visualization and quantification of the microstructure of the lung 
parenchyma were performed.14, 51   
 
Synchrotron x-ray tomographic microscopy (SRXTM) is another example of high-
resolution micro-CT imaging using synchrotron radiation x-rays as a monochromatic, 
coherent radiation source, providing even greater image resolution than can be achieved 
with conventional micro-CT (approximately 1µm) and the ability to perform phase contrast 
imaging52.  Recent advancements have enabled the use of this technique for serial imaging 
studies without adverse effects,53 and larger beamlines will enable application of SRTXM 
in larger animal studies.54  While SRXTM shows promise for in vivo studies of large 
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animals and humans in the future, these studies are currently performed using dedicated 
clinical imaging techniques. 
 
1.2.2 Clinical CT 
The discovery of x-ray Computed Tomography (CT)55 heralded a true paradigm shift in 
medicine and research.  Soon after its development in the 1970s, this groundbreaking 
technology was applied to pulmonary imaging.56  Early studies identified the utility of CT 
for studying structure, function, and biomechanics of the lungs through studies of 
ventilation in an animal model,57 and in imaging studies of breathing mechanics.58-60  
During this time, the first evaluations of lung biomechanics in humans were also made.61  
This marked the first use of pulmonary imaging for measurements and analysis of lung 
biomechanics, a field that has continued to develop as image acquisition and analysis 
techniques have evolved.  During this time, advancements in CT imaging provided the 
ability to image the anatomy, structure, and function of the lung with high spatial and 
temporal resolution.  Pulmonary CT has been used to study many pathologies, and is now 
the clinically accepted standard for the evaluation of severe emphysema in COPD62 and 
alpha-1 antitrypsin deficiency.63 CT provides regional lung tissue structural information 
and high-resolution methods that may be used to measure the airways and blood vessels, 
and to quantify emphysema or air trapping in the lung parenchyma with well-established 
radiodensity thresholds.63-65  The anatomical and structural information provided by CT 
can also be used to evaluate deformation and strain in the lung using CT images acquired 
at more than one lung volume.66  These measurements provide in vivo visualization and 
quantification of the kinematics of breathing, and how this may differ in some disease 
states.  From these measurements, information about structural and functional changes in 
the lung such as specific volume, which is correlated with specific ventilation, can be 
ascertained.67   
 
1.2.3 Magnetic Resonance Imaging 
Magnetic resonance imaging (MRI) provides soft tissue contrast that is not achievable 
using x-ray based methods like CT and does not carry the risk of ionizing radiation 
exposure.  However, its use was previously limited, as very little signal intensity is 
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measurable from lung parenchymal tissue due to very low proton density (and substantial 
gas density) and the millions of air-tissue interfaces in the lung parenchyma.68  In the early 
1990s, the application of ultra-short echo time (UTE) MRI  in lung imaging was 
investigated and used to increase the signal intensity measured in the lung tissue.69  UTE 
MRI enabled the acquisition of higher quality images of lung tissue and parenchyma, and 
represented the first application of advanced proton MRI techniques to anatomical lung 
imaging.  The other critical advancement in pulmonary MRI was the introduction of 
inhaled contrast agents for the assessment of lung function.  Using inhaled noble gases, 
such as hyperpolarized 3He and 129Xe, pulmonary ventilation may be visualized and 
quantified.  This was first demonstrated using hyperpolarized 129Xe,70 shortly followed by 
in vivo human lung imaging using both 3He71 and 129Xe72.  This functional imaging 
technique has since been widely applied in pulmonary imaging research. Inhaled 
hyperpolarized noble gas MRI can also be used to derive microstructural information from 
the diffusion of gas within the small airways and alveoli.73  
 
Since the first use of UTE MRI in lung imaging, other advanced proton MRI methods have 
been developed, including oxygen-enhanced MRI and Fourier decomposition (FD) MRI.  
Oxygen-enhanced MRI measures the effect of paramagnetic dissolved oxygen on the 1H 
signal74 and  has been acquired in both static (breath-hold) and dynamic (free-breathing) 
conditions to evaluate oxygenated air flow and the impact of this on signal relaxation in 
the lungs.  FDMRI, another free-breathing 1H MRI method, depends on the accurate co-
registration of images acquired throughout the breathing cycle.  The Fourier transform is 
used to transform the data in order to measure the 1H signal intensity changes in each voxel.  
These changes are due to the mechanics of breathing as the parenchyma expands and 
contracts with each breath.  Using the signal fluctuation at the respiratory rate, ventilation-
weighted images can be generated, whereas the signal fluctuations at the cardiac frequency 
(roughly 4 times greater than the respiratory rate) is used to generate perfusion maps.  
 
1.2.4 Overarching Rationale for Review 
Here we summarize recently developed pulmonary imaging tools and studies that were 
aimed at developing biomarkers and/or a deeper understanding of the biomechanics of 
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breathing and the respiratory system.  As shown in Table 2, where the key publications are 
summarized, numerous studies have been performed in large and small animal models, ex 
vivo in lung tissue samples as well as in vivo, in healthy volunteers and patients with 
respiratory disease.  Overall, this approach may be considered as an emerging field that 
will continue to evolve as imaging methods become less dependent upon physics expertise 
and image processing skills and more broadly used as standalone, turnkey systems for 
physiological investigations.  It is important to acknowledge that we focus necessarily on 
x-ray and MRI based methods in order to provide a review of the pulmonary imaging 
techniques that are applied most widely to studies of pulmonary structure, function and 
biomechanics, and are poised for application in physiological investigations outside of 
imaging research.   
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Table 4-2. Recent Pulmonary Imaging Studies of Biomechanics 
Method	 Investigation	
Model	
Imaging	Biomarker	 Biomechanics	
Measurement	
Citation*	
Micro-Computed	
Tomography	
	 	 	 	
Synchrotron	
radiation-based	x-ray	
tomographic	
microscopy	(SRXTM)	
Mouse	 Surface	area,	Volume,	
pressure	
Acinar	Deformation	 Sera	et	al.	J	Appl	
Physiol.	201313	
Synchrotron	
radiation-based	x-ray	
tomographic	
microscopy	(SRXTM)	
Mouse	 Airspace	morphometry	 Image-derived	flow	
simulation	
Sznitman	et	al.	J	
Vis	201011	
Synchrotron	
radiation-based	x-ray	
tomographic	
microscopy	(SRXTM)	
Mouse	 Airspace	morphometry	 Image-derived	flow	
simulation	
Sera	et	al.	
Comput	Methods	
Biomech	Biomed	
Engin	201512	
Micro	Computed	
Tomography	
Rat	 Airway	diameter,	
Volume	
Local	Compliance	 Sera	et	al.	J	Appl	
Physiol.	200410	
Micro	Computed	
Tomography	
Mouse	 Surface	area,	Volume	 Morphology	and	
Function	
Ford	et	al.	J	Appl	
Physiol	200714	
Micro-Computed	
Tomography	
Mouse	 Surface-to-volume	ratio	
at	different	pressures	
Acinar	Deformation	 Kumar	et	al.	J	
Appl	Physiol.	
201315	
X-Ray	Computed	
Tomography	
	 	 	 	
Xenon-enhanced	
Dual-energy	CT	
Human-	asthma	 Xenon	wash-in	and	
washout	
Airflow	 Kim	et	al.	Am	J	
Roentgenol.	
201227	
Xenon-enhanced	
Dual-energy	CT	
Human-	COPD	 Xenon	wash-in	(WI)	and	
washout	(WO)	
WI	and	WO	
relationship	to	
tissue	expansion	
Lee	et	al.	Eur	
Radiol	201728	
Inspiration-Expiration	
CT	
Canine	 Jacobian	determinant	 Compliance	 Kaczka	et	al.	Ann	
Biomed	Eng	
201120	
Inspiration-Expiration	
CT	
Human-	healthy		 Lobar	Deformation	 Lobar	mechanics	 Ding	et	al.	MICCAI	
200926	
Inspiration-Expiration	
CT	
Human-	healthy	
and	asthma	
Volume	change,	
Jacobian	determinant	
Deformation	 Choi	et	al.	J	Appl	
Physiol.	201316	
Inspiration-Expiration	
CT	
Human-	COPD	 Jacobian	determinant,	
Deformation	anisotropy	
Deformation,	strain	 Bodduluri		et	al.	
Acad	Radiol	
201317	
Multi-volume	CT	 Human-	healthy	 Volume	change,	
Jacobian	determinant	
Deformation,	strain	 Jahani	et	a.	J	
Biomech.	201423	
Inspiration-Expiration	
CT	
Human-	COPD	 Jacobian	determinant	 Deformation	 Bhatt	et	al.	Am	J	
Respir	Crit	Care	
Med.	201719	
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Inspiration-Expiration	
CT	
Human-	COPD	 Jacobian	determinant	 Deformation	 Bodduluri	et	al.	
Thorax.	201718	
4DCT	 Human-	healthy	 Jacobian	determinant,	
Deformation	anisotropy	
Deformation,	
hysteresis	
Jahani		et	al.	J	
Appl	Physiol	
201524	
4DCT	 Human-	healthy	
and	asthma	
Jacobian	determinant,	
Deformation	anisotropy	
Deformation,	
hysteresis	
Jahani		et	al.	J	
Biomech	201725	
Magnetic	Resonance	
Imaging	(MRI)	
	 	 	 	
Grid-tagged	
hyperpolarized	3He	
MRI	
Human-	
healthy,	
asthma,	and	
pulmonary	
fibrosis	
Deformation	 Deformation,	strain	 Tustison	et	al,	J	
Magn	Reson	
Imaging.	201021	
Static	Hyperpolarized		
3He	ventilation	
Human-	
healthy,	asthma	
Ventilation		 Airflow	and	its	
relationship	to	
mechanics	
Campana	et	al.	J	
Appl	Physiol	
200930	
Static	Hyperpolarized		
3He	ventilation	
Human-	
healthy,	asthma	
Ventilation		 Airflow	and	its	
relationship	to	
mechanics	
Lui	et	al.	PLoS	
One	201529	
Static	Hyperpolarized		
3He	ventilation	
Human-	
healthy,	asthma	
Ventilation		 Airflow	and	its	
relationship	to	
mechanics	
Leary	et	al.	
Physiol	Rep	
201631	
Hyperpolarized	noble	
gas	diffusion-
weighted	MRI	
	
Human-	COPD	 Apparent	diffusion	
coefficient,	surface	area,	
volume	
Transpulmonary	
pressure,	elasticity	
Choy	et	al.	J	Appl	
Physiol.	201737	
Dynamic	
Hyperpolarized	gas	
washout	
Human-	
healthy,	COPD	
Specific	Ventilation,	
alveolar	oxygen	tension	
Airflow	 Hamedani	et	al.	
Magn	Reson	Med	
201634	
Fourier	
Decomposition	
(FDMRI)	
Human-	COPD	 Ventilation	 Tissue	Expansion	 Capaldi	et	al.	
Acad	Radiol	
201532	
Fourier	
Decomposition	
(FDMRI)	
Human-	asthma	 Ventilation	 Tissue	Expansion	 Capaldi	et	al.	
Acad	Radiol	
210733	
Oxygen	enhanced	
(OEMRI)	
Human-	asthma	 Specific	Ventilation	 Airflow	 Ohno	et	al.	
Radiology	201436	
Oxygen	enhanced	
(OEMRI)	
Human-	healthy	 Specific	Ventilation	 Airflow	
distribution,	
gravitational	
dependence	
Sa	et	al.	J	Appl	
Physiol	201035	
*Citations are included in Reference section 
 
2.  Anatomical and Microstructural Imaging Biomarkers of Lung Biomechanics  
As shown in Table 1 and Figure 2, the structural/anatomical and fine details of the lung 
airways and parenchyma can be visualized and quantified using both x-ray based and MRI-
based imaging methods. Imaging provides the advantage of scalability from the laboratory 
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bench including ex vivo tissue samples and in vivo in small animal models to clinical 
research and investigations in vivo in individual patients.  Anatomical and microstructural 
lung biomarkers may be dynamically acquired during tidal breathing or in static breath-
hold to provide biomarkers of lung airways and parenchyma morphology.  Biomarkers 
related to the size, shape, and morphology of the airways and parenchyma may be used in 
combination with computational models75, 76 to generate biomechanical measurements of 
volume, pressure, and flow of air in the lung,37 and the forces generated in the process.37  
 
2.1  Biomarkers of Alveolar Morphology and Distension 
Figure 2 provides an overview of lung microstructural and micromechanical measurements 
and how these may be combined to better understand the relationship between larger-scale 
mechanical properties and the mechanics of the lung microstructure. For example, high 
resolution (up to 2µm/voxel) micro-computed tomography (micro-CT) of lung tissue can 
be acquired using either cone beam48, 77 or fan-beam micro-CT systems as well using 
synchrotron radiation x-ray tomographic microscopy (SRXTM), which uses a linear, 
monochromatic beam.  Using micro-CT, murine acinar ducts and alveoli may be visualized 
and directly measured, providing measurements acinar duct morphometry and 
deformation,15 as shown in Figure 3.  Early ex vivo studies,10, 78 which were used to probe 
local tissue compliance, preceded in vivo studies that required respiratory and cardiac 
gating techniques to overcome image artefacts and blurring due to the respiratory motion 
of tidal or ventilated breathing.14, 51  Retrospective and prospective respiratory gating 
techniques79 were later generated to systematically reduce motion blurring.  With the 
development of these methods, in vivo micro-CT in ventilated animals79 and small animal 
models of pulmonary disease14 have been performed to extend the findings revealed using 
ex vivo micro-CT of  excised samples of human lung tissue.42  In these in vivo studies, the 
morphology and function of the lung microstructure were further studied in ventilated 
mice.14  Micro-CT imaging has also been exploited to investigate animal models of 
emphysema,51 and using xenon gas contrast enhancement to measure ventilation80 as well 
as provide a detailed picture of lung microstructure81, 82 and mechanics in mouse models.15   
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Figure 4-3. Mouse Lung Micro-CT   
(A,B) Segmented micro-CT slices.  In the white text, A indicates a single alveolus 
highlighted in red, AW indicates the airway.  E indicates interalveolar septal edges. The 
boundary of the acinus is indicated in cyan.  (C) 3D reconstruction of the acinus, with 
substructures highlighted in pink, orange, and purple.  (D) Map of the Jacobian determinant 
with the acinus overlaid.  (Adapted with permission from Kumar et al. J Appl Physiol. 
2013;114(8):971-8.)15 
 
While SRXTM has not yet been demonstrated for in vivo patient studies, it provides greater 
spatial resolution (~1 µm) than micro-CT and has been used for small animal studies of 
lung morphometry.83, 84  In addition, the coherence of the synchrotron beam enables the 
acquisition of x-ray phase contrast imaging.  The use of phase contrast provides more 
sensitivity to airway structure, and increases the signal-to-noise ratio of the resulting 
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images.52  Phase contrast imaging also enables imaging measurements of ventilation, which 
have been validated with plethysmography.85  Rapid tomographic imaging has also been 
demonstrated which can has the potential to be used for 4D tomographic imaging.86  This 
has been applied to mammalian studies of ventilation in the airways and the parenchyma 
in vivo.87  As shown in Figure 4, high-resolution SRXTM images have been used in 
combination with computational fluid dynamics studies of aerosol deposition,11, 12  and in 
studies of lung mechanics.  For example, Figure 4 shows SRXTM and volume rendered 
images of a mouse lung at two inflation levels,13 where tissue deformation can clearly be 
visualized and quantified.  Moreover, morphometric SRXTM imaging of the mouse lung 
has been used to calculate the surface-to-volume ratio (S/V) at a known pressure, and 
deformable registration techniques were used to show that deformation of the acinus is 
anisotropic.15  SRXTM has also been used to image the kinematics of lung microstructure 
during breathing in a murine model, demonstrating directly that alveolar expansion is a 
heterogeneous process.13   
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Figure 4-4 Synchrotron Radiation X-ray Micro-CT of Mouse Lung Microstructure 
Deformation. 
Images of micro-CT (top) and volume rendering (center) of a mouse lung at FRC (A,C) 
and FRC+0.2L (B, D) showing deformation due to lung inflation.  Arrows indicate the 
alveolar ducts and septa in the right and left images. (E) A volume-rendering image of a 
mouse lung showing a conducting airway (star), bronchioles (triangle), and alveolar ducts 
(diamond).  (Adapted with permission from Sera et al. J Appl Physiol. 115, 219-28 
(2013).)13 
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Recently, a technique called dark-field imaging, in which absorption, phase and dark-field 
images can be acquired simultaneously, has been applied in lung imaging.  Dark-field 
image contrast is dependent on the scattering power of the sample, and it is therefore very 
sensitive to small structural changes in lung tissue.  It has been applied in emphysematous 
and healthy mice,88 and maps of emphysema generated with this technique have been 
verified with histology.89  It has also shown promise for the evaluation of pulmonary 
fibrosis in a murine model.90  Most recently, this technique has been applied in a living pig 
using clinically acceptable imaging parameters, showing the promise of dark-field imaging 
in human studies of lung disease.91  SRXTM and micro-CT are unique in their ability to 
provide non-invasive visualization and quantification of lung microstructure in small 
animals that would otherwise only be possible using histology.  This provides the ability 
to study the micromechanical processes involved in breathing in vivo, which are implicated 
in important processes such as particle deposition.11, 12   
 
2.2  Biomarkers from Regional Pressure-Volume Curves 
Inhaled hyperpolarized gas MRI can also be used to probe the microstructure of the lung 
by measuring the restricted Brownian motion of the inhaled gas in order to derive 
information about the size and shape of airspaces, which are abnormal in emphysema.73, 92, 
93  This is quantified by the apparent diffusion coefficient (ADC) of the inhaled gas.  This 
measurement has been shown to be strongly correlated with CT and histological measures 
of emphysema.94  Diffusion-weighted MRI has been used to measure local ADC gradients 
in healthy and diseased lung.  This measurement is sensitive to disease severity in COPD, 
providing additional insight to how COPD affects the mechanical properties of the tissue 
throughout the lung.95   
 
Using multiple b-values (related to specific gradients applied during MR imaging), other 
morphological values can be determined, such as the surface-to-volume ratio, airway 
radius, depth of the alveolar sleeve, and mean linear intercept.  MRI estimates of mean 
linear intercept have been verified using histological measurements of the same parameter 
in excised tissue,96, 97 which is a standard measure used to evaluate emphysema.98  
Therefore, diffusion-weighted pulmonary MRI provides a way to noninvasively quantify 
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airspace morphometry, and in vivo regional quantification of emphysema severity as has 
been accomplished using both 3He99 and 129Xe MRI.100  Figure 5 illustrates the 
quantification of ADC and mean linear intercept using both 3He and 129Xe imaging in an 
elderly never-smoker and ex-smokers with COPD, demonstrating that both ADC and mean 
linear intercept are elevated in COPD compared to elderly never-smokers.  
 
Figure 4-5. Diffusion-Weighted 3He and 129Xe MRI Mean Linear Intercept and ADC 
Maps 
Apparent diffusion coefficient (ADC) (top) and mean linear intercept (Lm) (bottom) maps 
generated using hyperpolarized 3He (upper) and 129Xe (lower) measurements in an elderly 
never-smoker (left), an ex-smoker with COPD (center), and subject with COPD caused by 
Alpha-1 antitrypsin deficiency (AATD) (right). 
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These measurements have been used to probe biomechanics of the lung, and were shown 
to be sensitive to COPD grade.95  As shown in Figure 6, diffusion-weighted MRI can probe 
the morphology of the airspaces to measure surface area (S) and volume (V).  Using 
micromechanical models, these measurements can be used to calculate transpulmonary 
pressure (Ptp) and pressure-volume curves using the following equation:37   
	 𝑃𝑡𝑝 𝑉 = 𝑁	𝐹 𝐿 𝐿3𝑉 + 2	𝛾 𝑆 𝑆3𝑉 + 𝑛	𝐹 𝑙 	𝑙3𝑉 	 (4.1)	
where surface area (S) and volume (V) are derived from MRI, and the following parameters 
describe the model tissue network: F(L) is the force exerted by the stretching of N 
(computed using FRC+1L lung volume) distinct line elements of length L (estimated from 
ADC measurements) in the parenchymal tissue, γ(S) describes the alveolar surface tension 
and F(l) represents the force exerted by n alveolar ducts of circumference l75, 101.  The above 
parameters were calculated using data and relationships described by Ingenito et al.101  
These microstructural and micromechanical measurements are unique in their ability to 
provide insight into structures too small to be directly measured in vivo.  Using these 
model-derived pressure-volume curves, a ‘shape factor’ (k) can be calculated by fitting the 
following equation to the experimental data using an iterative least squares method:37   
	 𝑉 𝑃 = 𝑉01d − (𝑉01d −	𝑉0De)𝑒[fg	 (4.2)	
This ‘shape factor’ (k) is a volume-independent measure of pulmonary elasticity.76  The 
combination of pulmonary imaging and micromechanical modeling enables in vivo 
measurements of mechanical properties of parenchymal tissue.  The ability to combine 
these techniques provides the opportunity to further probe the relationships between 
pulmonary imaging biomarkers and lung biomechanics. 
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Figure 4-6. Diffusion-weighted MRI Derived Regional Pressure-Volume Curves 
3He MRI was acquired with two diffusion weightings and the change in the measured 
signal intensity was used to calculate the apparent diffusion coefficient (ADC) on a voxel 
by voxel basis.  ADC values were used to calculate geometric parameters of the airway, 
including surface area and volume, assuming the geometry shown below on the right.  
Using these parameters, the transpulmonary pressure (Ptp) was calculated using the 
equation shown on the bottom right, derived from micromechanical models.  In this way, 
pulmonary pressure-volume curves (bottom left) can be derived from imaging data to probe 
regional pulmonary elasticity. Choy et al. 2010.37 
 
2.3  Biomarkers of Pulmonary Deformation during Breathing 
In contrast to small animal studies, the microstructure of the human lung cannot be directly 
imaged in vivo, due to the ionizing radiation dose and size constraints associated with 
micro-CT.  Human studies and clinical evaluations rely on the imaging of large-scale 
anatomical features and advanced image processing techniques to evaluate the mechanics 
of the lungs.  CT has been used for over 30 years to evaluate the mechanics of the lung and 
during breathing, first in animals,58, 60 and later in humans.61  It was also used for early in 
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vivo evaluations of the geometry and kinematics of breathing motion.57, 61, 102  As image 
acquisition and processing techniques have advanced, so have the imaging-derived metrics 
used to study mechanics.  Figure 7 summarizes a number of CT-derived metrics that are 
currently used to evaluate lung mechanics.  These include measurements of airway 
structure and geometry, gas trapping, global lung structure, and registration-based 
mechanical measurements of volume change and tissue deformation.  These measurements 
can be used to identify imaging phenotypes, which are correlated with clinical 
characteristics.103  In addition, airway measurements such as total airway length and branch 
count made using CT have been correlated with pulmonary function tests of lung 
biomechanics.104, 105   
 
Figure 4-7. Clinical CT Measurements of Pulmonary Structure and Function 
(A) An airway tree identifying structural components such as airway length and branching 
diameter. (B) A map of low-attenuating clusters (LAC) in an expiration CT image. (C) A 
segmented image identifying the size and shape of each lobe. (D) Maps of CT-derived 
functional biomechanical measurements. From left to right, the ratio of air-volume change 
in the upper lobes (U) to the middle and lower lobes (M+L), the Jacobian determinant, and 
the anisotropic deformation index (ADI). (Adapted with permission from Choi et al. J 
Allergy Clin Immunol (2017).)103 
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By acquiring thoracic CT images at different phases in the breathing cycle (i.e. full 
inspiration and full expiration), anatomical biomarkers may be generated and used to 
quantify forces and strain within the lung.  Using non-rigid or deformable image 
registration methods,106-108 lung deformations during the breathing cycle can be 
evaluated.66 Biomarkers of lung deformation also include measures of local volume 
change, estimates of tissue compliance and deformation biomarkers during breathing.  For 
example, upon co-registration of images acquired at different phases in the breathing cycle, 
vector maps can be created to describe local tissue deformation related to the differences 
in the two original images.  A Jacobian matrix can be applied to this vector field (D) using 
the following: 
	 𝐽 𝑥, 𝑦, 𝑧 = 1 +
𝜕𝐷d𝜕𝑥 𝜕𝐷d𝜕𝑦 𝜕𝐷d𝜕𝑧𝜕𝐷l𝜕𝑥 1 + 𝜕𝐷l𝜕𝑦 𝜕𝐷l𝜕𝑧𝜕𝐷m𝜕𝑥 𝜕𝐷m𝜕𝑦 1 + 𝜕𝐷m𝜕𝑧
	 (4.3)	
 
where Dx is the x component of the vector field D, and 𝜕Dx/	𝜕x is the partial derivative of 
D with respect to x.  The determinant of the Jacobian matrix (called the Jacobian 
determinant) is a measure related to the change in specific volume,67  which has been shown 
to reflect regional ventilation.22  Thus, the Jacobian determinant is a biomechanical 
measure that is directly related to lung function. 
 
Using multi-volume CT, Jacobian biomarkers of lung deformation have been evaluated in 
patients with obstructive lung disease including severe asthmatics16, 25 and COPD 
participants in the COPDgene study.17-19  Differences and abnormal lung biomechanical 
properties have been quantified in severe asthmatics including a diminished volume change 
during breathing, suggestive of gas-trapping.16  In COPD patients, CT-derived biomarkers 
of lung biomechanics are sensitive to GOLD stage,17 disease progression,19 and clinical 
outcomes.18  Figure 8 provides an example of deformable registration of multi-volume CT 
whereby the Jacobian determinant of voxels within 2mm of emphysema voxels were 
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shown to be related to disease progression.  This finding strongly suggests that 
biomechanical lung measurements made using CT provide a way to identify lung 
abnormalities that are not yet detected as emphysema.19  CT-derived deformation maps 
have also been used to evaluate the biomechanics of  the lung lobes independently in order 
to gain a deeper understanding of how the lobar surfaces slide against each other during 
breathing.26   While these techniques have been primarily applied to static images acquired 
at inspiration and expiration, they have recently been applied to images acquired under 
free-breathing conditions, as discussed further in section 3.2 
 
Figure 4-8. Mapping the Distance between Healthy and Emphysematous Voxels 
(A) Inspiration and expiration images are deformably co-registered. (B) Emphysematous 
regions in the inspiration image are identified (voxels with attenuation <-950 HU).  (C) 
Normal tissue voxels are clustered based on their Euclidean distance to the nearest 
emphysema voxel.  (D) Color map showing the distance of each normal voxel to the nearest 
emphysema voxel.  (Reproduced with permission from Bhatt et al. Am J Respir Crit Care 
Med. 2017.)19 
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3.  Functional Imaging Biomarkers of Pulmonary Biomechanics 
While the primary function of the lungs is to facilitate gas exchange, the biomechanical 
properties of the lungs are defined by the interdependent relationships between pressure 
and volume that drive lung ventilation.  This process can be studied using both static and 
dynamic imaging approaches.  Here, we summarize multiple ways in which pulmonary 
imaging can be used to visualize and quantify ventilation.  
 
3.1  Breath-hold Ventilation Imaging Biomarkers as Predictors of Airway Resistance 
Hyperpolarized noble gas MRI is used to capture a static image of ventilation.  To acquire 
this image, patients are instructed to inhale a known volume of hyperpolarized noble gas, 
and images are acquired during a 10-16 second breath-hold. Well-ventilated regions fill 
with hyperpolarized gas, and a bright signal is measured.  However, in regions where 
airflow is obstructed or filling constants are longer than the 10-16 seconds necessary for 
image acquisition, little signal is measured and these areas appear as a dark void in the 
image.  These dark voids are called ventilation defects, and correspond to regions of the 
lung that are poorly ventilated.109  In this way, inhaled hyperpolarized gas MRI can be used 
to visualize and quantify the distribution of inhaled gas within the lungs.  The normalized 
volume of ventilation defects in the lung is called the ventilation defect percent (VDP), and 
is a sensitive imaging biomarker used in research to evaluate diseases such as asthma and 
COPD.  Figure 9 shows 3He and 129Xe static ventilation maps for a healthy never-smoker, 
a subject with COPD, and a subject with asthma.  Pulmonary MRI can be used to identify 
the size, shape, and distribution of ventilation defects throughout the lung.  This 
measurement has been validated in many disease states, and is sensitive to changes due to 
provocation110, 111 or treatment.  Static ventilation measurements using hyperpolarized 3He 
MRI have been used to show response to bronchodilator treatment in asthma112, 113 and 
COPD,114 and MRI ventilation heterogeneity has been shown to be an independent 
predictor of asthma control.115  As shown in Figure 9, 3He and 129Xe provide very similar 
imaging information.  However, differences have been observed in both COPD116 and 
asthma.113  These differences are important for researchers to be aware of during the 
ongoing transition from 3He to 129Xe MRI due to restricted supply and rising costs of 
3He.117 
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Figure 4-9. Static Breath-hold 3He and 129Xe Ventilation MRI 
Hyperpolarized 3He (left) and 129Xe (right) static ventilation magnetic resonance images of 
a healthy never-smoker (top), an ex-smoker with COPD (center), and a subject with asthma 
(bottom).  Helium is shown in cyan and Xenon is shown in violet co-registered to a 
greyscale anatomical image. 
 
The information derived from ventilation MRI is complementary to the biomechanical 
information that is acquired using pulmonary function tests.  In order to understand the 
biomechanical measurements derived from the forced oscillation technique (FOT), recent 
studies have used combinations of measured and model-derived lung impedance estimates 
and measures of MRI-derived ventilation heterogeneity in order to probe the relationships 
between them.  Lui et al. demonstrated that the coefficient of variation of 3He MRI 
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ventilation is significantly correlated with respiratory impedance, as well as airway 
hyperresponsiveness in asthma.29  Hyperpolarized 3He MRI and image functional 
modeling have been used to study the relationship between airway closure and model-
predicted ventilation distributions; these results support the hypothesis that small airway 
dysfunction is a crucial component of airway narrowing in ventilation defects.30 In another 
recent study, model-predicted ventilation distributions were used to support the hypothesis 
that the heterogeneity of intrinsic properties of lung tissue likely contributes to 
heterogeneous ventilation.118  Patient-specific ventilation maps derived from 3He MRI 
have also been used with an asymmetric-branching airway tree model to generate estimates 
of airway impedance in asthma.31  The combination of ventilation MRI and computational 
modelling of airway mechanics provide complementary information that may provide a 
better understanding of the underlying biomechanical mechanisms that cause ventilation 
defects in obstructive lung disease. 
 
3.2  Dynamic Ventilation Imaging of Biomechanical Changes During the 
Respiratory Cycle 
Ventilation is a dynamic process, and this aspect of its nature can be captured in dynamic 
ventilation images using dual-energy xenon CT, multi-breath hyperpolarized gas MRI, 
oxygen-enhanced MRI, and Fourier Decomposition MRI.  Xenon-enhanced CT (Xe-CT) 
is a free-breathing technique used to measure the wash-in and washout of inhaled xenon.  
Animal studies performed using this technique have shown that the time for washout is 
greater than for wash-in.119  This technique has been applied in human studies to evaluate 
asthma,27 and has been shown to be feasible for the diagnosis of pulmonary embolism.120   
In a recent COPD study, wash-in and washout times were shown to be correlated with 
measures of lung tissue expansion derived from virtual, non-contrast CT images at 
inspiration and expiration.28 
 
Hyperpolarized noble gas MRI can also be used to acquire dynamic images of ventilation.  
In multi-breath wash-in MRI, the signal increase is measured as the subject inhales multiple 
doses of hyperpolarized 3He gas.121  In multi-breath inert gas washout imaging, the subject 
breathes normally after inhaling a single volume of hyperpolarized noble gas and the 
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decrease in signal intensity is measured as the gas is washed out of the subject’s lungs.122, 
123  Recently, both wash-in and washout imaging were combined in a single protocol, and 
used to evaluate healthy subjects, asymptomatic smokers, and subjects with COPD.34  
Using this protocol, COPD subjects and smokers were shown to have reduced mean 
specific ventilation as compared to healthy never-smokers.  Dynamic ventilation imaging 
may be able to differentiate between slow-filling regions of the lung and regions where 
absolutely no ventilation is present, which is unattainable with static breath-hold imaging.   
The techniques applied to multi-volume CT imaging in section 2.3 can also be applied to 
images at different points in the respiratory cycle, which enables measurements of lung 
deformation throughout the cycle rather than only at end inspiration and end expiration23.  
Using four-dimensional CT (4DCT), images are reconstructed at many points throughout 
the breathing cycle, and changes in volume can be measured throughout the entire process.  
This technique was used to show that deformation throughout the respiratory cycle is 
nonlinear, and demonstrates hysteresis.24  This non-linearity and hysteresis have been 
shown to be greater in asthmatics than in healthy subjects.25  4DCT images have also been 
used in the development of computational fluid dynamics models to study the mechanics 
and dynamics of the lungs in silico.124  
 
CT deformation techniques provide unique information that is complementary to 
measurements derived from the forced oscillation technique in an animal model of lung 
injury.20  In this animal study, transrespiratory pressure was also measured, and a Jacobian-
based estimate for total respiratory compliance (𝐶nonp1q ) was determined using the equation 
below.  
	 𝐶nonp1q = 𝑉e∆𝑃1s ( 𝐽e − 1)teuY 	 (4.4)	
In the above equation, n denotes a single voxel, Vn is the volume of the voxel element, ΔPao 
is the overall transrespiratory pressure change, and Jn is the Jacobian. Using a combination 
of direct mechanical measurements and pulmonary imaging, voxel-wise measurements of 
mechanical properties of the tissue can be made.   
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Using MRI, lung deformations have been measured using hyperpolarized 3He71 and grid-
tagging methods adapted from cardiac imaging.125  First demonstrated at very low field 
strength (0.15T) in a healthy volunteer,126 this was later demonstrated at clinical field 
strengths in healthy volunteers.127, 128  This technique has been adapted for 3D image 
acquisition and analysis, and can be used to quantify kinematics and mechanics regionally 
in both healthy and diseased lung.21  This imaging tool has been used in the development 
of computational modeling of respiratory motion, providing the physiological information 
needed to advance computational models.129  
 
MRI methods may also be employed that rely on the change in pulmonary proton signal 
measured during breathing, including oxygen-enhanced MRI (OEMRI)74 and Fourier 
decomposition MRI (FDMRI).130  Static OE imaging can be used to identify ventilation 
defects, or areas of low signal enhancement.74  Recently, the feasibility of 3D isotropic 
OEMR imaging was demonstrated in healthy adults using an ultra-short echo time (UTE) 
pulse sequence.131  Dynamic OEMRI is used to measure the wash-in and washout of gas 
in a two-dimensional slice over time.  Dynamic OEMRI measures of wash-in and washout 
are correlated with diffusing capacity (DLCO) and FEV1,132 and demonstrate the 
gravitational dependence of specific ventilation in a supine subject.35  Oxygen enhanced 
MRI has been used to evaluate ventilation in cystic fibrosis,133 COPD,134 and asthma,36 and 
has comparable effectiveness to CT for clinical staging and evaluation of asthma.135  
FDMRI has been investigated in several diseases including COPD, bronchiectasis and 
severe asthma.32, 33  FDMRI ventilation measurements at 3T are correlated with 3He 
measurements of ventilation in COPD32 and asthma,32, 33  demonstrating the relationship 
between the signal observed in ventilation-weighted FDMRI and the ventilation 
distribution observed using 3He MRI.  Both of these techniques are able to probe functional 
changes that occur in asthma and COPD as a result of structural and mechanical changes 
such as tissue destruction and airway remodeling.   
 
Figure 10 shows FDMRI in subjects with asthma, bronchiectasis, and COPD.  
Hyperpolarized 3He ventilation  and CT images are shown for each subject, and it is clear 
that ventilation defects identified using FDMRI and hyperpolarized noble gas MRI are 
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spatially related.  This technique is particularly interesting for the study of ventilation and 
biomechanics because the measurements of ventilation are directly related to the 
mechanical expansion of the lungs.136  This highlights the fundamental relationship 
between ventilation and other biomechanical properties in the lung.   
 
Figure 4-10. Ventilation MRI and CT of Obstructive Lung Disease 
Hyperpolarized 3He MRI (left), Fourier decomposition (FD) MRI (center) and x-ray CT of 
subjects with asthma (top), bronchiectasis (center), and COPD (bottom).  Helium in cyan 
and FDMRI ventilation in magenta are co-registered to a greyscale anatomical image. 
 
4.  Discussion and Future Work  
Over the past five decades, pulmonary x-ray and MRI-based imaging tools and biomarkers 
have been developed and applied to the study of lung biomechanics.  As summarized in 
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Table 2, these methods have provided biomarkers and measurements stemming from ex 
vivo tissue and animal studies as well as in vivo investigations in small animal models and 
patients or healthy volunteers.  In combination, functional and structural lung imaging 
provides a wealth of information that can be used to generate a deeper understanding of 
lung biomechanics.  As shown in Figure 11 in 3D, co-registered functional MRI and 
anatomical CT images can be used to quantify abnormal airways and parenchymal tissue, 
identifying abnormal regions of the lung where either or both structure and function are 
impacted.  Together, with measurements of biomechanics made at the mouth and the 
imaging biomarkers themselves, there is the potential for regional insights that cannot be 
derived by any one measurement alone.  This is important because lung disease is spatially 
heterogeneous, and pulmonary imaging helps to identify and measure regional and local 
lung structure and function abnormalities.  These include microstructural techniques such 
as micro-CT and diffusion-weighted hyperpolarized MRI, and anatomical imaging 
techniques such as multi-volume CT and MRI.  There have also been several functional 
techniques developed, including static and dynamic ventilation CT and MRI techniques 
with or without inhaled contrast agents.  More work is required and future studies will 
likely include the development of advanced image acquisition and processing techniques 
in order to develop new biomarkers that may provide a deeper understanding of lung 
biomechanics in health and disease.  As pulmonary imaging technologies continue to 
improve, so should our ability to probe the relationships between the biomechanical 
properties of the lung tissue and structural and functional changes in vivo.  This is important 
as we embark on new cell and scaffold-based therapies of lung disease that require a deeper 
understanding of how lung biomechanics relates to lung structure-function. 
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Figure 4-11. MR and CT Imaging of Lung Structure and Function 
Function hyperpolarized 3He MRI (cyan) is shown co-registered to structural CT 
(greyscale) with a 3D rendering of the airway tree (yellow) for two asthmatic subjects. (S1) 
Subject 1: female, age=30yrs, FEV1=71%pred , R(5Hz)=10cmH2O*s/L, R(5-
19Hz)=4cmH2O*s/L. (S2) Subject 2: female, age=34yrs, FEV1=50%pred , 
R(5Hz)=6cmH2O*s/L, R(5-19Hz)=3cmH2O*s/L. 
 
5. Conclusions 
Recent advancements in thoracic imaging including x-ray based methods (micro-CT, 
clinical CT) as well as conventional and inhaled gas MRI provide a way to generate never-
before possible biomarkers of lung structure and function.  This imaging data may be 
acquired in tissue samples, animal models and patients and include high spatial and 
temporal resolution biomarkers and biomechanical information.  Beyond the 
measurements that pulmonary function tests, multiple breath washout studies and FOT 
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provide, lung imaging can localize lung biomechanical abnormalities.  As pulmonary 
imaging continues to develop and is translated into clinical use, it will continue to provide 
new and critically-needed insights into the relationships between lung structure, function 
and biomechanics. 
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